"questions": [
	{
		"body": "Is Rheumatoid Arthritis more common in men or women?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24107643"
			"http://www.ncbi.nlm.nih.gov/pubmed/23974974"
			"http://www.ncbi.nlm.nih.gov/pubmed/23916348"
			"http://www.ncbi.nlm.nih.gov/pubmed/23900228"
			"http://www.ncbi.nlm.nih.gov/pubmed/23873887"
			"http://www.ncbi.nlm.nih.gov/pubmed/23812032"
			"http://www.ncbi.nlm.nih.gov/pubmed/23703486"
			"http://www.ncbi.nlm.nih.gov/pubmed/23553100"
			"http://www.ncbi.nlm.nih.gov/pubmed/23526031"
			"http://www.ncbi.nlm.nih.gov/pubmed/23423442"
			"http://www.ncbi.nlm.nih.gov/pubmed/23264337"
			"http://www.ncbi.nlm.nih.gov/pubmed/23217568"
			"http://www.ncbi.nlm.nih.gov/pubmed/23006836"
			"http://www.ncbi.nlm.nih.gov/pubmed/22833513"
			"http://www.ncbi.nlm.nih.gov/pubmed/22828565"
			"http://www.ncbi.nlm.nih.gov/pubmed/22825589"
			"http://www.ncbi.nlm.nih.gov/pubmed/22717204"
			"http://www.ncbi.nlm.nih.gov/pubmed/22577060"
			"http://www.ncbi.nlm.nih.gov/pubmed/22505696"
			"http://www.ncbi.nlm.nih.gov/pubmed/22462416"
			"http://www.ncbi.nlm.nih.gov/pubmed/22455933"
			"http://www.ncbi.nlm.nih.gov/pubmed/22388357"
			"http://www.ncbi.nlm.nih.gov/pubmed/22300712"
			"http://www.ncbi.nlm.nih.gov/pubmed/22204900"
			"http://www.ncbi.nlm.nih.gov/pubmed/22108779"
			"http://www.ncbi.nlm.nih.gov/pubmed/21881200"
			"http://www.ncbi.nlm.nih.gov/pubmed/21834821"
			"http://www.ncbi.nlm.nih.gov/pubmed/21619489"
			"http://www.ncbi.nlm.nih.gov/pubmed/21459948"
		],
		"triples": [
		],
		"id": "5118dd1305c10fae75000001",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22825589"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "183"
				"text": "Introduction
The prevalence, course and severity of many common traits and diseases, including autoimmune diseases,1 cardiovascular diseases2 and asthma3 differ between men and women."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23006836"
				"endSection": "sections.0"
				"offsetInBeginSection": "798"
				"offsetInEndSection": "961"
				"text": "The WHO has specifically identified four major disabling MSK conditions: osteoarthritis (OA), rheumatoid arthritis (RA), osteoporosis (OP), and back pain (BP) [4]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22825589"
				"endSection": "sections.0"
				"offsetInBeginSection": "184"
				"offsetInEndSection": "301"
				"text": "For example, the prevalence of type 1 diabetes (T1D) and type 2 diabetes (T2D) in women is 58% and 47%, respectively."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22455933"
				"endSection": "sections.0"
				"offsetInBeginSection": "2576"
				"offsetInEndSection": "2910"
				"text": "The level of exposure to mineral oil via cosmetic use is probably essentially lower than the level we previously analysed in the context of occupational exposure [18], but exposure via cosmetic use is very common, especially among women, and even a small increase in risk of RA might be of importance from a public health perspective."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22455933"
				"endSection": "sections.0"
				"offsetInBeginSection": "1195"
				"offsetInEndSection": "1501"
				"text": "In the context of mineral oil, we investigated the arthritogenic capacity of common cosmetics that are known to contain high amounts of mineral oils, and we observed that several such cosmetics could induce arthritis in the DA strain of rats when administered subcutaneously as well as percutaneously [16]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22455933"
				"endSection": "sections.0"
				"offsetInBeginSection": "390"
				"offsetInEndSection": "547"
				"text": "In particular, very little information exists in humans on environmental factors with a known capacity to induce arthritis in experimental arthritis systems."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22455933"
				"endSection": "sections.0"
				"offsetInBeginSection": "1502"
				"offsetInEndSection": "1819"
				"text": "It has not been established whether similar mechanisms - that is, polyarthritis induced by simple adjuvants - are operative also in human arthritis, although case reports on arthritis development after adjuvant exposures suggested that rodents and humans might both react to adjuvants with arthritis development [17]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22455933"
				"endSection": "sections.0"
				"offsetInBeginSection": "223"
				"offsetInEndSection": "389"
				"text": "Whereas knowledge of the genetic basis of this disease is rapidly advancing [3-5], there is a scarcity of data on environmental agents that may cause arthritis [6-9]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22455933"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "222"
				"text": "Introduction
Rheumatoid arthritis (RA) is a disease that is dependent on genetic as well as environmental factors, as seen from both concordance data in twins and from a number of epidemiological and genetic studies [1,2]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22455933"
				"endSection": "sections.0"
				"offsetInBeginSection": "548"
				"offsetInEndSection": "795"
				"text": "Agents that are able to induce experimental arthritis in animals, particularly in rats, include a number of adjuvants originating from microbes such as bacteria, yeast and viruses [10,11] as well as from other sources such as mineral oils [12-14]."
			}
		],
		"id": "5118dd1305c10fae75000001",
	},
	{
		"body": "Are there any DNMT3 proteins present in plants?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24327140"
			"http://www.ncbi.nlm.nih.gov/pubmed/24316013"
			"http://www.ncbi.nlm.nih.gov/pubmed/24127215"
			"http://www.ncbi.nlm.nih.gov/pubmed/24127212"
			"http://www.ncbi.nlm.nih.gov/pubmed/24123478"
			"http://www.ncbi.nlm.nih.gov/pubmed/24098800"
			"http://www.ncbi.nlm.nih.gov/pubmed/23894490"
			"http://www.ncbi.nlm.nih.gov/pubmed/23852726"
			"http://www.ncbi.nlm.nih.gov/pubmed/23836914"
			"http://www.ncbi.nlm.nih.gov/pubmed/23688924"
			"http://www.ncbi.nlm.nih.gov/pubmed/23626723"
			"http://www.ncbi.nlm.nih.gov/pubmed/23611774"
			"http://www.ncbi.nlm.nih.gov/pubmed/23484688"
			"http://www.ncbi.nlm.nih.gov/pubmed/23159436"
			"http://www.ncbi.nlm.nih.gov/pubmed/22995292"
			"http://www.ncbi.nlm.nih.gov/pubmed/22972351"
			"http://www.ncbi.nlm.nih.gov/pubmed/22642896"
			"http://www.ncbi.nlm.nih.gov/pubmed/22481891"
			"http://www.ncbi.nlm.nih.gov/pubmed/22450363"
			"http://www.ncbi.nlm.nih.gov/pubmed/23552838"
			"http://www.ncbi.nlm.nih.gov/pubmed/22174693"
			"http://www.ncbi.nlm.nih.gov/pubmed/22140515"
			"http://www.ncbi.nlm.nih.gov/pubmed/22122805"
			"http://www.ncbi.nlm.nih.gov/pubmed/22088914"
			"http://www.ncbi.nlm.nih.gov/pubmed/22081970"
			"http://www.ncbi.nlm.nih.gov/pubmed/21695170"
			"http://www.ncbi.nlm.nih.gov/pubmed/21666679"
			"http://www.ncbi.nlm.nih.gov/pubmed/21549127"
			"http://www.ncbi.nlm.nih.gov/pubmed/21541319"
		],
		"triples": [
		],
		"id": "511a16f9df1ebcce7d000005",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24098800"
				"endSection": "sections.0"
				"offsetInBeginSection": "5642"
				"offsetInEndSection": "5937"
				"text": "In addition to EST library construction, we explored the possibility of DNA methylation in the three termite species by examining whether gene sequences of DNA (cytosine-5) methyltransferases, namely, dnmt1, dnmt2 and dnmt3, and methyl-CpG binding domain, mbd, were present in the EST libraries."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24127215"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "247"
				"text": "Introduction
One defining characteristic of stem cells is their ability to divide asymmetrically, such that one daughter cell self-renews to remain stem, whereas the other daughter cell commits to lineage-specific differentiation (Knoblich, 2008)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24127215"
				"endSection": "sections.0"
				"offsetInBeginSection": "248"
				"offsetInEndSection": "618"
				"text": "This often coincides with asymmetric inheritance of macromolecules to the daughter cells, for example, misfolded proteins (Rujano et al., 2006), centrioles (Yamashita et al., 2007), and the younger versus older replicated chromatids in different organisms, such as bacteria (Lark, 1966), plants (Lark, 1967), filamentous fungi (Rosenberger and Kessel, 1968), or mammals."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24127215"
				"endSection": "sections.0"
				"offsetInBeginSection": "619"
				"offsetInEndSection": "930"
				"text": "In mammals, it has been described in a variety of cell types: epithelium (Potten et al., 1978), intestine (Potten et al., 2002; Falconer et al., 2010; Quyn et al., 2010), mammary (Smith, 2005), neural (Karpowicz et al., 2005), and muscle (Shinin et al., 2006; Conboy et al., 2007; Rocheteau et al., 2012) cells."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24127215"
				"endSection": "sections.0"
				"offsetInBeginSection": "931"
				"offsetInEndSection": "1187"
				"text": "The earliest observations led to the immortal DNA strand hypothesis, postulating that stem cells avoid accumulating mutations arising from DNA replication by consecutively and infinitely segregating old DNA strands in the stem daughter cell (Cairns, 1975)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24127215"
				"endSection": "sections.0"
				"offsetInBeginSection": "1188"
				"offsetInEndSection": "1773"
				"text": "Aspects of this hypothesis and the underlying phenomenon have been debated (Lansdorp, 2007; Rando, 2007; Steinhauser et al., 2012) because of the lack of evidence supporting the infinite ability of stem cells to sort their DNA, conflicting studies in similar tissues (Potten et al., 2002; Falconer et al., 2010; Quyn et al., 2010; Escobar et al., 2011; Schepers et al., 2011), and the reported inability of some other tissue-specific stem cells to segregate DNA strands nonrandomly, such as blood (Kiel et al., 2007), hair (Waghmare et al., 2008), and skin (Sotiropoulou et al., 2008)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24127215"
				"endSection": "sections.0"
				"offsetInBeginSection": "1774"
				"offsetInEndSection": "1924"
				"text": "Nevertheless, a growing body of evidence supports DNA strand nonrandom template segregation (NRTS) in a variety of asymmetrically dividing stem cells."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24127215"
				"endSection": "sections.0"
				"offsetInBeginSection": "1925"
				"offsetInEndSection": "2086"
				"text": "Asymmetric segregation of epigenetically unequal sister chromatids might be required to affect gene expression and consequently cell fate in asymmetric division."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24127215"
				"endSection": "sections.0"
				"offsetInBeginSection": "2087"
				"offsetInEndSection": "2258"
				"text": "Moreover, such distinct epigenetic marks between sister chromatids might be necessary to sort older versus younger DNA strands during mitosis (Klar, 1994; Lansdorp, 2007)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24127215"
				"endSection": "sections.0"
				"offsetInBeginSection": "2259"
				"offsetInEndSection": "2519"
				"text": "However, before this current work, these notions remained undemonstrated, and the identification of epigenetic marks had been poorly—if at all—documented (Huh and Sherley, 2011), perhaps because of the lack of an in vitro cellular model exhibiting robust NRTS."
			}
		],
		"id": "511a16f9df1ebcce7d000005",
	},
	{
		"body": "What is the most prominent sequence consensus for the polyadenylation site?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/18487515"
			"http://www.ncbi.nlm.nih.gov/pubmed/16006100"
			"http://www.ncbi.nlm.nih.gov/pubmed/10720434"
			"http://www.ncbi.nlm.nih.gov/pubmed/10072078"
			"http://www.ncbi.nlm.nih.gov/pubmed/6312290"
			"http://www.ncbi.nlm.nih.gov/pubmed/11894958"
		],
		"triples": [
		],
		"id": "5133b9455274a5fb0700000c",
	},
		"triples": [
		],
		"id": "5133b9455274a5fb0700000c",
	},
	{
		"body": "What is the function of the mammalian gene Irg1?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/23931757"
			"http://www.ncbi.nlm.nih.gov/pubmed/23610393"
			"http://www.ncbi.nlm.nih.gov/pubmed/23609450"
			"http://www.ncbi.nlm.nih.gov/pubmed/23455712"
			"http://www.ncbi.nlm.nih.gov/pubmed/22698585"
			"http://www.ncbi.nlm.nih.gov/pubmed/21947773"
			"http://www.ncbi.nlm.nih.gov/pubmed/21836375"
			"http://www.ncbi.nlm.nih.gov/pubmed/21424586"
			"http://www.ncbi.nlm.nih.gov/pubmed/20536725"
			"http://www.ncbi.nlm.nih.gov/pubmed/19014335"
			"http://www.ncbi.nlm.nih.gov/pubmed/18522745"
			"http://www.ncbi.nlm.nih.gov/pubmed/16951324"
			"http://www.ncbi.nlm.nih.gov/pubmed/16415166"
			"http://www.ncbi.nlm.nih.gov/pubmed/16116224"
			"http://www.ncbi.nlm.nih.gov/pubmed/15937114"
			"http://www.ncbi.nlm.nih.gov/pubmed/15178747"
			"http://www.ncbi.nlm.nih.gov/pubmed/14500577"
			"http://www.ncbi.nlm.nih.gov/pubmed/12893884"
			"http://www.ncbi.nlm.nih.gov/pubmed/12356687"
			"http://www.ncbi.nlm.nih.gov/pubmed/11356686"
			"http://www.ncbi.nlm.nih.gov/pubmed/10707257"
			"http://www.ncbi.nlm.nih.gov/pubmed/10489423"
			"http://www.ncbi.nlm.nih.gov/pubmed/7721348"
		],
		"triples": [
		],
		"id": "513832a75274a5fb07000012",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23455712"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "94"
				"text": "Virus infection of mammalian cells induces signaling pathways that promote an antiviral state."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/18522745"
				"endSection": "sections.0"
				"offsetInBeginSection": "1260"
				"offsetInEndSection": "1480"
				"text": "We thus reasoned that it should be possible to dissect the membrane away from the overlying tissues and use this isolated membrane to study tissue-wide gene expression changes in an inflamed tissue of minimal complexity."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23455712"
				"endSection": "sections.0"
				"offsetInBeginSection": "95"
				"offsetInEndSection": "394"
				"text": "RNA intermediates of virus replication are recognized by pathogen recognition receptors (PRR), such as Toll-like receptors (TLR) and RIG-I-like receptors (RLR), which signal specific transcription factors to induce innate defense programs, including type I interferon (IFN) expression and secretion."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23455712"
				"endSection": "sections.0"
				"offsetInBeginSection": "395"
				"offsetInEndSection": "599"
				"text": "Binding of IFN to IFN-αβ receptor (Ifnar) on infected and uninfected cells results in a signaling cascade that restricts infection of many viruses through expression of interferon-stimulated genes (ISGs)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23455712"
				"endSection": "sections.0"
				"offsetInBeginSection": "600"
				"offsetInEndSection": "800"
				"text": "Several studies report that type I IFN receptor-knockout mice (Ifnar−/−) exhibit enhanced mortality after viral infection due to increased viral burden and expanded tropism in neurons of the brain1,2."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/18522745"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "142"
				"text": "Introduction
The murine air pouch is an easily accessible bursa-like space that can be produced de novo in the dorsal subcutaneous tissue [1]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/18522745"
				"endSection": "sections.0"
				"offsetInBeginSection": "143"
				"offsetInEndSection": "369"
				"text": "Within several days of injecting a small volume of air (2 to 3 ml), a membrane of several layers of cells, which consist mostly of fibroblasts, mononuclear cells and small blood vessels, grows around this air-filled space [1]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/18522745"
				"endSection": "sections.0"
				"offsetInBeginSection": "370"
				"offsetInEndSection": "559"
				"text": "This membrane resembles the synovial membrane histologically and has important properties of the synovial lining, such as hyaluronic acid synthesis [2] and expression of the Ia antigen [1]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/18522745"
				"endSection": "sections.0"
				"offsetInBeginSection": "560"
				"offsetInEndSection": "713"
				"text": "Inflammatory substances or micro-organisms can be injected easily into the pouch, leading to different forms of inflammation depending on the agent used."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/18522745"
				"endSection": "sections.0"
				"offsetInBeginSection": "714"
				"offsetInEndSection": "933"
				"text": "For instance, inflammation caused by monosodium urate (MSU) [3] and calcium pyrophosphate crystals [4], carrageenan [4], joint prosthesis debris [5] and bacterial cell wall components [6] has been studied in this model."
			}
		],
		"id": "513832a75274a5fb07000012",
	},
	{
		"body": "Is thrombophilia related to increased risk of miscarriage?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24200686"
			"http://www.ncbi.nlm.nih.gov/pubmed/24082554"
			"http://www.ncbi.nlm.nih.gov/pubmed/23999648"
			"http://www.ncbi.nlm.nih.gov/pubmed/23954867"
			"http://www.ncbi.nlm.nih.gov/pubmed/23809122"
			"http://www.ncbi.nlm.nih.gov/pubmed/23715104"
			"http://www.ncbi.nlm.nih.gov/pubmed/23587581"
			"http://www.ncbi.nlm.nih.gov/pubmed/23400304"
			"http://www.ncbi.nlm.nih.gov/pubmed/22160027"
			"http://www.ncbi.nlm.nih.gov/pubmed/22023244"
			"http://www.ncbi.nlm.nih.gov/pubmed/21869933"
			"http://www.ncbi.nlm.nih.gov/pubmed/21346577"
			"http://www.ncbi.nlm.nih.gov/pubmed/21241403"
			"http://www.ncbi.nlm.nih.gov/pubmed/21239788"
			"http://www.ncbi.nlm.nih.gov/pubmed/21039385"
			"http://www.ncbi.nlm.nih.gov/pubmed/20605623"
			"http://www.ncbi.nlm.nih.gov/pubmed/20563311"
			"http://www.ncbi.nlm.nih.gov/pubmed/20403270"
			"http://www.ncbi.nlm.nih.gov/pubmed/20185181"
			"http://www.ncbi.nlm.nih.gov/pubmed/20083915"
			"http://www.ncbi.nlm.nih.gov/pubmed/20063840"
			"http://www.ncbi.nlm.nih.gov/pubmed/20008211"
			"http://www.ncbi.nlm.nih.gov/pubmed/19937485"
			"http://www.ncbi.nlm.nih.gov/pubmed/19912516"
			"http://www.ncbi.nlm.nih.gov/pubmed/19786941"
			"http://www.ncbi.nlm.nih.gov/pubmed/19203641"
			"http://www.ncbi.nlm.nih.gov/pubmed/19228606"
			"http://www.ncbi.nlm.nih.gov/pubmed/19132175"
			"http://www.ncbi.nlm.nih.gov/pubmed/18803625"
		],
		"triples": [
		],
		"id": "513cdc38bee46bd34c000007",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21869933"
				"endSection": "sections.0"
				"offsetInBeginSection": "1837"
				"offsetInEndSection": "2041"
				"text": "The prothrombin G20210A mutation seems to increase the risk of thrombosis in pregnant women by approximately tenfold [18] with the risk of developing obstetric complications increased by fourfold    [16]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21869933"
				"endSection": "sections.0"
				"offsetInBeginSection": "1542"
				"offsetInEndSection": "1678"
				"text": "Other known SNPs associated with thrombophilia and adverse outcomes during pregnancy are prothrombin G20210A and MTHFR C677T    [15–17]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21869933"
				"endSection": "sections.0"
				"offsetInBeginSection": "3"
				"offsetInEndSection": "59"
				"text": "Introduction
Pregnancy increases the risk of thrombosis."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/20563311"
				"endSection": "sections.0"
				"offsetInBeginSection": "332"
				"offsetInEndSection": "427"
				"text": "Thrombophilia describes an increased tendency to develop thrombosis, either venous or arterial."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/20563311"
				"endSection": "sections.0"
				"offsetInBeginSection": "1042"
				"offsetInEndSection": "1251"
				"text": "Individual case control studies variably demonstrate an association between the placenta-mediated pregnancy complications and thrombophilia but when meta-analysed suggest a weak positive association [13]–[15]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/20563311"
				"endSection": "sections.0"
				"offsetInBeginSection": "1630"
				"offsetInEndSection": "1731"
				"text": "Prospective cohort studies also provide absolute risk estimates that can be used to counsel patients."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/20563311"
				"endSection": "sections.0"
				"offsetInBeginSection": "825"
				"offsetInEndSection": "1041"
				"text": "It is hypothesised that thrombophilias may increase the risk of placental insufficiency because of placental micro- and/or macro-vascular thrombosis, as well as effects on trophoblast growth and differentiation [12]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/20563311"
				"endSection": "sections.0"
				"offsetInBeginSection": "1732"
				"offsetInEndSection": "1967"
				"text": "Our objective was to undertake a systematic review and a meta-analysis of prospective cohort studies to estimate the risk of these common and important placenta-mediated pregnancy complications in the women with and without FVL or PGM."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21869933"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "2"
				"text": "1."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21869933"
				"endSection": "sections.0"
				"offsetInBeginSection": "60"
				"offsetInEndSection": "198"
				"text": "APCR phenotype has been associated with venous thromboembolism (VTE), the primary cause of maternal death in developed countries    [1–3]."
			}
		],
		"id": "513cdc38bee46bd34c000007",
	},
	{
		"body": "Which extra thyroid tissues have thyrotropin (TSH) receptors?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/19553036"
			"http://www.ncbi.nlm.nih.gov/pubmed/18400223"
			"http://www.ncbi.nlm.nih.gov/pubmed/14669949"
			"http://www.ncbi.nlm.nih.gov/pubmed/12515285"
			"http://www.ncbi.nlm.nih.gov/pubmed/11399468"
			"http://www.ncbi.nlm.nih.gov/pubmed/7794253"
			"http://www.ncbi.nlm.nih.gov/pubmed/8320423"
		],
		"triples": [
		],
		"id": "513f45abbee46bd34c000013",
	},
		"triples": [
		],
		"id": "513f45abbee46bd34c000013",
	},
	{
		"body": "What is the methyl donor of DNA (cytosine-5)-methyltransferases?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24205358"
			"http://www.ncbi.nlm.nih.gov/pubmed/24141114"
			"http://www.ncbi.nlm.nih.gov/pubmed/23724145"
			"http://www.ncbi.nlm.nih.gov/pubmed/23576011"
			"http://www.ncbi.nlm.nih.gov/pubmed/23408989"
			"http://www.ncbi.nlm.nih.gov/pubmed/23183753"
			"http://www.ncbi.nlm.nih.gov/pubmed/23030620"
			"http://www.ncbi.nlm.nih.gov/pubmed/22945834"
			"http://www.ncbi.nlm.nih.gov/pubmed/22558281"
			"http://www.ncbi.nlm.nih.gov/pubmed/22438930"
			"http://www.ncbi.nlm.nih.gov/pubmed/22260147"
			"http://www.ncbi.nlm.nih.gov/pubmed/21949694"
			"http://www.ncbi.nlm.nih.gov/pubmed/21735817"
			"http://www.ncbi.nlm.nih.gov/pubmed/19451595"
			"http://www.ncbi.nlm.nih.gov/pubmed/17440941"
			"http://www.ncbi.nlm.nih.gov/pubmed/17259861"
			"http://www.ncbi.nlm.nih.gov/pubmed/17107663"
			"http://www.ncbi.nlm.nih.gov/pubmed/16855792"
			"http://www.ncbi.nlm.nih.gov/pubmed/16829525"
			"http://www.ncbi.nlm.nih.gov/pubmed/15195996"
			"http://www.ncbi.nlm.nih.gov/pubmed/12538347"
			"http://www.ncbi.nlm.nih.gov/pubmed/11208790"
			"http://www.ncbi.nlm.nih.gov/pubmed/11087417"
			"http://www.ncbi.nlm.nih.gov/pubmed/9461031"
			"http://www.ncbi.nlm.nih.gov/pubmed/8918941"
			"http://www.ncbi.nlm.nih.gov/pubmed/8625314"
			"http://www.ncbi.nlm.nih.gov/pubmed/7578083"
			"http://www.ncbi.nlm.nih.gov/pubmed/8645558"
			"http://www.ncbi.nlm.nih.gov/pubmed/8065896"
		],
		"triples": [
		],
		"id": "51404dd723fec90375000002",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24205358"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "232"
				"text": "Introduction
DNA (cytosine-5) methylation is catalyzed by C5-methyltransferases (C5-MTase), which transfer a methyl group from the methyl donor S-adenosyl-methionine (SAM) onto carbon 5 of cytosines in specific nucleotide sequences."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24205358"
				"endSection": "sections.0"
				"offsetInBeginSection": "823"
				"offsetInEndSection": "1007"
				"text": "It was observed that the CCGG-specific prokaryotic C5-MTase M.HpaII can catalyze conversion of the target cytosine to uracil when the methyl donor SAM is missing from the reaction [5]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23408989"
				"endSection": "sections.0"
				"offsetInBeginSection": "1504"
				"offsetInEndSection": "1608"
				"text": "Both DNA and protein methyltransferases use S-adenosylmethionine (AdoMet) as the methyl group donor [3]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24205358"
				"endSection": "sections.0"
				"offsetInBeginSection": "2548"
				"offsetInEndSection": "2735"
				"text": "Under conditions where deamination of cytosine was enhanced almost 100-fold by M.SssI and 5’-amino-5’-deoxyadenosine, we could not detect M.SssI-catalyzed deamination of 5-methylcytosine."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22438930"
				"endSection": "sections.0"
				"offsetInBeginSection": "2034"
				"offsetInEndSection": "2282"
				"text": "It occurs by transfer of a methyl group from S-adenosyl methionine (SAM), a universal methyl group donor in biochemical reactions in cells, to cytosine residues at the dinucletide sequence CpG, and is catalyzed by DNA methytransferases (DNMTs) [9]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23408989"
				"endSection": "sections.0"
				"offsetInBeginSection": "1703"
				"offsetInEndSection": "1859"
				"text": "AdoHcy is a competitive inhibitor of most AdoMet-dependent methyltransferases because it binds to their active sites with a higher affinity than AdoMet [5]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22558281"
				"endSection": "sections.0"
				"offsetInBeginSection": "2411"
				"offsetInEndSection": "2667"
				"text": "Intracellular arsenic metabolism and DNA methylation require S-adenosylmethionine (SAM) as a methyl donor, and the consumption of methyl groups in arsenic biotransformation presumably results in a deficiency of methyl donors, reducing DNA methylation [10]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23408989"
				"endSection": "sections.0"
				"offsetInBeginSection": "105"
				"offsetInEndSection": "308"
				"text": "DNA methylation is an important epigenetic mechanism of gene regulation that, in differentiated cells, occurs almost exclusively by methylation of cytosine at CpG dinucleotides, forming 5-methylcytosine."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24205358"
				"endSection": "sections.0"
				"offsetInBeginSection": "2736"
				"offsetInEndSection": "2860"
				"text": "We constructed a mutant M.SssI, which showed cytosine deaminase activity in E. coli, at physiological concentrations of SAM."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23408989"
				"endSection": "sections.0"
				"offsetInBeginSection": "309"
				"offsetInEndSection": "372"
				"text": "DNA methylation is catalyzed by DNA methyltransferases (DNMTs)."
			}
		],
		"id": "51404dd723fec90375000002",
	},
	{
		"body": "Super-SILAC is a method used in quantitative proteomics. What is the super-SILAC mix? (SILAC: Stable Isotopic labelling by aminoacids in cell culture)",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24309976"
			"http://www.ncbi.nlm.nih.gov/pubmed/23929719"
			"http://www.ncbi.nlm.nih.gov/pubmed/23906570"
			"http://www.ncbi.nlm.nih.gov/pubmed/23606247"
			"http://www.ncbi.nlm.nih.gov/pubmed/23603340"
			"http://www.ncbi.nlm.nih.gov/pubmed/23442083"
			"http://www.ncbi.nlm.nih.gov/pubmed/23362377"
			"http://www.ncbi.nlm.nih.gov/pubmed/23033477"
			"http://www.ncbi.nlm.nih.gov/pubmed/22575385"
			"http://www.ncbi.nlm.nih.gov/pubmed/22535442"
			"http://www.ncbi.nlm.nih.gov/pubmed/22083085"
			"http://www.ncbi.nlm.nih.gov/pubmed/21959240"
			"http://www.ncbi.nlm.nih.gov/pubmed/21890006"
			"http://www.ncbi.nlm.nih.gov/pubmed/21597922"
			"http://www.ncbi.nlm.nih.gov/pubmed/21575137"
			"http://www.ncbi.nlm.nih.gov/pubmed/20864298"
			"http://www.ncbi.nlm.nih.gov/pubmed/20515019"
			"http://www.ncbi.nlm.nih.gov/pubmed/20451407"
			"http://www.ncbi.nlm.nih.gov/pubmed/20127688"
			"http://www.ncbi.nlm.nih.gov/pubmed/19896555"
			"http://www.ncbi.nlm.nih.gov/pubmed/19622376"
			"http://www.ncbi.nlm.nih.gov/pubmed/19605366"
			"http://www.ncbi.nlm.nih.gov/pubmed/19562805"
			"http://www.ncbi.nlm.nih.gov/pubmed/19449810"
			"http://www.ncbi.nlm.nih.gov/pubmed/19398346"
			"http://www.ncbi.nlm.nih.gov/pubmed/19194975"
			"http://www.ncbi.nlm.nih.gov/pubmed/19106162"
			"http://www.ncbi.nlm.nih.gov/pubmed/19053080"
			"http://www.ncbi.nlm.nih.gov/pubmed/19006335"
		],
		"triples": [
		],
		"id": "51430930d24251bc0500000b",
	},
		"triples": [
		],
		"id": "51430930d24251bc0500000b",
	},
	{
		"body": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24319020"
			"http://www.ncbi.nlm.nih.gov/pubmed/24302194"
			"http://www.ncbi.nlm.nih.gov/pubmed/24300902"
			"http://www.ncbi.nlm.nih.gov/pubmed/24299284"
			"http://www.ncbi.nlm.nih.gov/pubmed/24293149"
			"http://www.ncbi.nlm.nih.gov/pubmed/24261501"
			"http://www.ncbi.nlm.nih.gov/pubmed/24254381"
			"http://www.ncbi.nlm.nih.gov/pubmed/24251163"
			"http://www.ncbi.nlm.nih.gov/pubmed/24247580"
			"http://www.ncbi.nlm.nih.gov/pubmed/24218143"
			"http://www.ncbi.nlm.nih.gov/pubmed/24183932"
			"http://www.ncbi.nlm.nih.gov/pubmed/24158184"
			"http://www.ncbi.nlm.nih.gov/pubmed/24100728"
			"http://www.ncbi.nlm.nih.gov/pubmed/24074368"
			"http://www.ncbi.nlm.nih.gov/pubmed/24072553"
			"http://www.ncbi.nlm.nih.gov/pubmed/24061519"
			"http://www.ncbi.nlm.nih.gov/pubmed/24058102"
			"http://www.ncbi.nlm.nih.gov/pubmed/24058099"
			"http://www.ncbi.nlm.nih.gov/pubmed/24014553"
			"http://www.ncbi.nlm.nih.gov/pubmed/24014011"
			"http://www.ncbi.nlm.nih.gov/pubmed/24010542"
			"http://www.ncbi.nlm.nih.gov/pubmed/24008099"
			"http://www.ncbi.nlm.nih.gov/pubmed/23994879"
			"http://www.ncbi.nlm.nih.gov/pubmed/23961499"
			"http://www.ncbi.nlm.nih.gov/pubmed/23928057"
			"http://www.ncbi.nlm.nih.gov/pubmed/23913169"
			"http://www.ncbi.nlm.nih.gov/pubmed/23913001"
			"http://www.ncbi.nlm.nih.gov/pubmed/23877214"
			"http://www.ncbi.nlm.nih.gov/pubmed/23850066"
		],
		"triples": [
		],
		"id": "51477de5d24251bc05000020",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24251163"
				"endSection": "sections.0"
				"offsetInBeginSection": "500"
				"offsetInEndSection": "689"
				"text": "VIPoma cases may be associated with multiple endocrine neoplasia type 1 (MEN 1).[2] Here we report a case of VIPoma (as a component of MEN 1 syndrome) with stroke as a presenting complaint."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23961499"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "516"
				"text": "INTRODUCTION
Thymic neuroendocrine (NE) tumors associated with multiple endocrine neoplasia type 1 (MEN-1) are rare, variably documented in 1-8% cases.[1234] Thymic NE tumors are usually detected about 7-29 years following surgical treatment of primary hyperparathyroidism (PHPT) in MEN-1.[3] Transcervical thymectomy (TCT) at the time of parathyroid surgery for PHPT usually prevents thymic NE tumors.[1] The occurrence of thymic NE tumors is very rare after TCT as part of the parathyroidectomy procedure for PHPT."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24251163"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "193"
				"text": "INTRODUCTION
Verner and Morrison described a syndrome of watery diarrhea, hypokalemia, and achlorhydria (WDHA) in 1958.[1] VIPomas producing high amounts of vasoactive intestinal peptide (VIP)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24251163"
				"endSection": "sections.0"
				"offsetInBeginSection": "359"
				"offsetInEndSection": "499"
				"text": "Morbidity from untreated WDHA syndrome is associated with long standing dehydration and with electrolyte and acid-base metabolism disorders."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23961499"
				"endSection": "sections.0"
				"offsetInBeginSection": "517"
				"offsetInEndSection": "668"
				"text": "Here we report a case of thymic NE carcinoma developing within a span of 8 months after subtotal parathyroidectomy and TCT for PHPT in a MEN-1 patient."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23913001"
				"endSection": "sections.0"
				"offsetInBeginSection": "373"
				"offsetInEndSection": "509"
				"text": "About 5% of patients referred to hypertension clinics (1 to 10 million people world-wide) have aldosterone-producing adenomas (APAs)3,4."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24251163"
				"endSection": "sections.0"
				"offsetInBeginSection": "194"
				"offsetInEndSection": "244"
				"text": "These tumors commonly originate from the pancreas."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24251163"
				"endSection": "sections.0"
				"offsetInBeginSection": "245"
				"offsetInEndSection": "358"
				"text": "Diarrhea with flushing may persist for years before the diagnosis and association with renal failure is reported."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23913001"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "113"
				"text": "Aldosterone is normally produced in response to volume depletion (via angiotensin II signaling) or hyperkalemia2."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23913001"
				"endSection": "sections.0"
				"offsetInBeginSection": "114"
				"offsetInEndSection": "248"
				"text": "Aldosterone signaling defends intravascular volume by increasing intestinal and renal Na-Cl absorption and reabsorption, respectively."
			}
		],
		"id": "51477de5d24251bc05000020",
	},
	{
		"body": "What is the mechanism of action of anticoagulant medication Dabigatran?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24319220"
			"http://www.ncbi.nlm.nih.gov/pubmed/24259703"
			"http://www.ncbi.nlm.nih.gov/pubmed/24214790"
			"http://www.ncbi.nlm.nih.gov/pubmed/24212379"
			"http://www.ncbi.nlm.nih.gov/pubmed/24212377"
			"http://www.ncbi.nlm.nih.gov/pubmed/24127705"
			"http://www.ncbi.nlm.nih.gov/pubmed/24084970"
			"http://www.ncbi.nlm.nih.gov/pubmed/24030706"
			"http://www.ncbi.nlm.nih.gov/pubmed/24029592"
			"http://www.ncbi.nlm.nih.gov/pubmed/23957907"
			"http://www.ncbi.nlm.nih.gov/pubmed/23922182"
			"http://www.ncbi.nlm.nih.gov/pubmed/23918529"
			"http://www.ncbi.nlm.nih.gov/pubmed/23909016"
			"http://www.ncbi.nlm.nih.gov/pubmed/23869941"
			"http://www.ncbi.nlm.nih.gov/pubmed/23860880"
			"http://www.ncbi.nlm.nih.gov/pubmed/23855420"
			"http://www.ncbi.nlm.nih.gov/pubmed/23846055"
			"http://www.ncbi.nlm.nih.gov/pubmed/23841763"
			"http://www.ncbi.nlm.nih.gov/pubmed/23838557"
			"http://www.ncbi.nlm.nih.gov/pubmed/23816779"
			"http://www.ncbi.nlm.nih.gov/pubmed/23790595"
			"http://www.ncbi.nlm.nih.gov/pubmed/23784163"
			"http://www.ncbi.nlm.nih.gov/pubmed/23770747"
			"http://www.ncbi.nlm.nih.gov/pubmed/23687449"
			"http://www.ncbi.nlm.nih.gov/pubmed/23634926"
			"http://www.ncbi.nlm.nih.gov/pubmed/23626566"
			"http://www.ncbi.nlm.nih.gov/pubmed/23611064"
			"http://www.ncbi.nlm.nih.gov/pubmed/23594983"
			"http://www.ncbi.nlm.nih.gov/pubmed/23581981"
		],
		"triples": [
		],
		"id": "51485a4dd24251bc0500002a",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23687449"
				"endSection": "sections.0"
				"offsetInBeginSection": "1824"
				"offsetInEndSection": "2023"
				"text": "Stroke prevention in patients with AF focuses on anticoagulant agents, including warfarin (a vitamin K antagonist), which effectively reduce the risk of stroke by preventing blood clots from forming."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23626566"
				"endSection": "sections.0"
				"offsetInBeginSection": "198"
				"offsetInEndSection": "463"
				"text": "In 2009, three large phase III trials of three novel oral anticoagulants, the direct thrombin inhibitor dabigatran and the factor Xa inhibitors rivaroxaban and apixaban, showed non-inferiority concerning efficacy and safety of these drugs in comparison to warfarin."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23687449"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "436"
				"text": "Introduction
Atrial fibrillation (AF) is a common cardiac arrhythmia and a well-established risk factor for stroke.1,2 Patients with AF have a four- to five-times greater risk of stroke or transient ischemic attack compared with those without AF.1,3 In addition, strokes that occur in patients with AF are associated with an increased risk of premature death and disability.4–10
AF is an especially important concern among older adults."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23687449"
				"endSection": "sections.0"
				"offsetInBeginSection": "437"
				"offsetInEndSection": "795"
				"text": "Prevalence of AF increases with patient age (Figure 1)3,11 and, in the USA, approximately 82% of patients with AF are ≥ 65 years old and 37% are ≥ 80 years old.3 The rate of stroke in patients with AF increases substantially in patients aged 80–89 years, with an attributable risk of 23.5%.1 As age increases, the risk of complications from stroke increases."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23687449"
				"endSection": "sections.0"
				"offsetInBeginSection": "796"
				"offsetInEndSection": "1230"
				"text": "The CHADS2 score – calculated based on presence of Congestive heart failure (either systolic or diastolic), Hypertension, Age ≥ 75 years, Diabetes mellitus, and history of Stroke or transient ischemic attack – is used to estimate a patient’s long-term risk of stroke.12 Points are assigned to each of the included risk factors, with two points assigned for history of stroke, and total scores range from 0 (low risk) to 6 (high risk)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23687449"
				"endSection": "sections.0"
				"offsetInBeginSection": "1231"
				"offsetInEndSection": "1622"
				"text": "A modified version of the CHADS2, the CHA2DS2-VASc score, considers the following additional risk factors for stroke in patients with AF: vascular disease (such as myocardial infarction [MI], complex aortic plaque, and peripheral artery disease), female sex, and age 65–74 years.13 The CHA2DS2-VASc score places greater emphasis on age ≥ 75 years by assigning two points to this risk factor."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23687449"
				"endSection": "sections.0"
				"offsetInBeginSection": "1623"
				"offsetInEndSection": "1823"
				"text": "Because the prevalence of many of the risk factors included in CHADS2 and CHA2DS2-VASc also increases with age,14–16 age is a dichotomous variable in the calculation of CHADS2 and CHA2DS2-VASc scores."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23687449"
				"endSection": "sections.0"
				"offsetInBeginSection": "2024"
				"offsetInEndSection": "2382"
				"text": "However, warfarin has a narrow therapeutic window, is associated with an increased risk of bleeding including intracranial hemorrhage (ICH), and requires frequent monitoring.17 These limitations have prompted the development of a novel group of anticoagulants, which may be particularly helpful when considering stroke prevention in elderly patients with AF."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23626566"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "197"
				"text": "Introduction
For more than 50 years, treatment with vitamin K antagonists had been the only therapeutic option to prevent strokes and other embolic events in patients with atrial fibrillation (AF)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23626566"
				"endSection": "sections.0"
				"offsetInBeginSection": "464"
				"offsetInEndSection": "800"
				"text": "While the individual phase III trials of each of the novel oral anticoagulants (NOA) were not powered to detect a difference in stroke risk or mortality, a meta-analysis of these trials (RE-LY [1], ROCKET-AF [2] and ARISTOTLE [3]) demonstrated a significant decrease of stroke risk and mortality under NOA in comparison to warfarin [4]."
			}
		],
		"id": "51485a4dd24251bc0500002a",
	},
	{
		"body": "Is Mammaprint approved by the United States Food and Drug Administration?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/19585214"
			"http://www.ncbi.nlm.nih.gov/pubmed/19546609"
			"http://www.ncbi.nlm.nih.gov/pubmed/23485165"
			"http://www.ncbi.nlm.nih.gov/pubmed/18515733"
		],
		"triples": [
		],
		"id": "51487821d24251bc0500002f",
	},
		"triples": [
		],
		"id": "51487821d24251bc0500002f",
	},
	{
		"body": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24291968"
			"http://www.ncbi.nlm.nih.gov/pubmed/24220173"
			"http://www.ncbi.nlm.nih.gov/pubmed/24164490"
			"http://www.ncbi.nlm.nih.gov/pubmed/24145588"
			"http://www.ncbi.nlm.nih.gov/pubmed/24141560"
			"http://www.ncbi.nlm.nih.gov/pubmed/24112993"
			"http://www.ncbi.nlm.nih.gov/pubmed/24095170"
			"http://www.ncbi.nlm.nih.gov/pubmed/24088269"
			"http://www.ncbi.nlm.nih.gov/pubmed/23938353"
			"http://www.ncbi.nlm.nih.gov/pubmed/23909021"
			"http://www.ncbi.nlm.nih.gov/pubmed/23893883"
			"http://www.ncbi.nlm.nih.gov/pubmed/23823963"
			"http://www.ncbi.nlm.nih.gov/pubmed/23794683"
			"http://www.ncbi.nlm.nih.gov/pubmed/23768983"
			"http://www.ncbi.nlm.nih.gov/pubmed/23678983"
			"http://www.ncbi.nlm.nih.gov/pubmed/23670841"
			"http://www.ncbi.nlm.nih.gov/pubmed/23559196"
			"http://www.ncbi.nlm.nih.gov/pubmed/23537506"
			"http://www.ncbi.nlm.nih.gov/pubmed/23535158"
			"http://www.ncbi.nlm.nih.gov/pubmed/23452772"
			"http://www.ncbi.nlm.nih.gov/pubmed/23460475"
			"http://www.ncbi.nlm.nih.gov/pubmed/23440963"
			"http://www.ncbi.nlm.nih.gov/pubmed/23423465"
			"http://www.ncbi.nlm.nih.gov/pubmed/23381166"
			"http://www.ncbi.nlm.nih.gov/pubmed/23376659"
			"http://www.ncbi.nlm.nih.gov/pubmed/23341732"
			"http://www.ncbi.nlm.nih.gov/pubmed/23337001"
			"http://www.ncbi.nlm.nih.gov/pubmed/23279780"
			"http://www.ncbi.nlm.nih.gov/pubmed/23278581"
		],
		"triples": [
		],
		"id": "5149199dd24251bc05000040",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24088269"
				"endSection": "sections.0"
				"offsetInBeginSection": "2999"
				"offsetInEndSection": "3207"
				"text": "Our primary goal was to test the hypothesis that MG severity is associated with symptoms of autonomic disturbance, and a secondary goal was to document the prevalence of fatigue in myasthenia gravis patients."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23341732"
				"endSection": "sections.0"
				"offsetInBeginSection": "1715"
				"offsetInEndSection": "1927"
				"text": "We did a systematic PubMed search using the search terms “myasthenia gravis” and “antisense oligonucleotides” and appropriate citations were manually selected from the search results for inclusion in this review."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23341732"
				"endSection": "sections.0"
				"offsetInBeginSection": "1170"
				"offsetInEndSection": "1433"
				"text": "AChE inhibitors were among the earliest treatment options for MG and they remain one of the most widely used drug options.4 They are used as symptomatic treatment: slowing the degradation of ACh at the NMJ, they provide a temporary improvement in muscle strength."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24088269"
				"endSection": "sections.0"
				"offsetInBeginSection": "2376"
				"offsetInEndSection": "2568"
				"text": "This syndrome responded to acetylcholine esterase inhibitors (AChEI) [15], which could indicate that presynaptic impairment is an underlying cause of the autonomic disturbances in MG patients."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24088269"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "188"
				"text": "Background
Myasthenia gravis (MG) is a chronic autoimmune disease that affects the neuromuscular junction, causing reduced muscular strength and reduced endurance of repetitive muscle use."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23341732"
				"endSection": "sections.0"
				"offsetInBeginSection": "1595"
				"offsetInEndSection": "1714"
				"text": "In this review, we present a summary of current treatment progresses in managing MG, regarding the symptomatic therapy."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23341732"
				"endSection": "sections.0"
				"offsetInBeginSection": "945"
				"offsetInEndSection": "1169"
				"text": "Binding of ACh to its receptor is a short-lived phenomenon: it rapidly fades away because of the decrease of its concentration within the synaptic cleft, due to diffusion processes and acetylcholinesterase (AChE) hydrolysis."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23341732"
				"endSection": "sections.0"
				"offsetInBeginSection": "1434"
				"offsetInEndSection": "1594"
				"text": "ACh inhibitors are used as adjunctive therapy in patients receiving immunomodulatory agents (such as steroids) that represent the usual long-term immunotherapy."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23341732"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "489"
				"text": "Introduction
Myasthenia gravis (MG) is an autoimmune disorder caused by autoantibodies binding to the nicotinic acetylcholine receptor (nAChR) on the postsynaptic membrane at the neuromuscular junction (NMJ),1 or, less frequently, to a muscle-specific tyrosine kinase (MuSK), an AChR-associated protein involved in clustering of AChRs and expressed in mature NMJ.2 In MG, the binding of autoantibodies to AChRs or MuSK results in an abnormal neuromuscular transmission and muscle weakness."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24088269"
				"endSection": "sections.0"
				"offsetInBeginSection": "189"
				"offsetInEndSection": "318"
				"text": "Fatigue has been reported in both neurological and non-neurological diseases, including MG, independent of muscle weakness [1,2]."
			}
		],
		"id": "5149199dd24251bc05000040",
	},
	{
		"body": "Which medication should be administered when managing patients with suspected acute opioid overdose?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/23972442"
			"http://www.ncbi.nlm.nih.gov/pubmed/23925669"
			"http://www.ncbi.nlm.nih.gov/pubmed/23647815"
			"http://www.ncbi.nlm.nih.gov/pubmed/23628523"
			"http://www.ncbi.nlm.nih.gov/pubmed/23372174"
			"http://www.ncbi.nlm.nih.gov/pubmed/23350582"
			"http://www.ncbi.nlm.nih.gov/pubmed/22895794"
			"http://www.ncbi.nlm.nih.gov/pubmed/22890688"
			"http://www.ncbi.nlm.nih.gov/pubmed/22541710"
			"http://www.ncbi.nlm.nih.gov/pubmed/22479887"
			"http://www.ncbi.nlm.nih.gov/pubmed/22346054"
			"http://www.ncbi.nlm.nih.gov/pubmed/22204885"
			"http://www.ncbi.nlm.nih.gov/pubmed/22027217"
			"http://www.ncbi.nlm.nih.gov/pubmed/21981435"
			"http://www.ncbi.nlm.nih.gov/pubmed/21824056"
			"http://www.ncbi.nlm.nih.gov/pubmed/21668760"
			"http://www.ncbi.nlm.nih.gov/pubmed/21667674"
			"http://www.ncbi.nlm.nih.gov/pubmed/21467284"
			"http://www.ncbi.nlm.nih.gov/pubmed/21193765"
			"http://www.ncbi.nlm.nih.gov/pubmed/21030851"
			"http://www.ncbi.nlm.nih.gov/pubmed/20938327"
			"http://www.ncbi.nlm.nih.gov/pubmed/20888607"
			"http://www.ncbi.nlm.nih.gov/pubmed/20877175"
			"http://www.ncbi.nlm.nih.gov/pubmed/20142694"
			"http://www.ncbi.nlm.nih.gov/pubmed/19876859"
			"http://www.ncbi.nlm.nih.gov/pubmed/19378534"
			"http://www.ncbi.nlm.nih.gov/pubmed/19332974"
			"http://www.ncbi.nlm.nih.gov/pubmed/18503626"
			"http://www.ncbi.nlm.nih.gov/pubmed/18338302"
		],
		"triples": [
		],
		"id": "5149f494d24251bc0500004c",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22346054"
				"endSection": "sections.0"
				"offsetInBeginSection": "1494"
				"offsetInEndSection": "2070"
				"text": "Dexmedetomidine has been gaining popularity in controlling withdrawal symptoms associated with varieties of substance abuse and dependences and has been successfully used to facilitate withdrawal of prolonged sedation in ICU.[1210–14]
We are reporting a case of an acute, severe overdose of an opioid (heroin) in an opioid addict complicated by rhabdomyolysis leading to acute renal failure and later development of adult respiratory distress syndrome (ARDS) which leads to a prolonged ICU stay in which prolonged dexmedetomidine was used to facilitate the withdrawal process."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22346054"
				"endSection": "sections.0"
				"offsetInBeginSection": "336"
				"offsetInEndSection": "1061"
				"text": "An acute withdrawal of these illicit drugs is associated with agitation, restlessness, insomnia, generalized muscle and joint pain anxiety, dysphoria, and various psychomimetic disturbances,[1] and most of these symptoms are caused by central nervous system (CNS) hyperactivity and are very distressing which frequently lead to relapse to drug use.[23] Acute intoxication and withdrawal of some illicit drugs are often associated with severe and life-threatening complications such as rhabdomyolysis,[4] acute renal failure,[45] neurological complication,[5] acute pulmonary edema,[6] ARDS,[67] etc., which not only prolonged the intensive care unit (ICU) stay but also made the withdrawal and detoxification process complex."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22346054"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "111"
				"text": "INTRODUCTION
Substance abuse often leads to emergency hospital admission for various life-threatening symptoms."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22346054"
				"endSection": "sections.0"
				"offsetInBeginSection": "112"
				"offsetInEndSection": "335"
				"text": "The presenting symptoms are often multiple, misdiagnosed, and often inconsistent because of variable dosage and adulteration of drugs, a mixed intoxication–withdrawal state, and sometimes adverse or idiosyncratic reactions."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22346054"
				"endSection": "sections.0"
				"offsetInBeginSection": "1062"
				"offsetInEndSection": "1493"
				"text": "In addition, critically ill patients who received long-term sedative–analgesic therapy in ICU developed functional tolerance and experienced withdrawal symptoms similar to those patients addicted to narcotics, alcohol, or other stimulant drugs.[8–10] So far we do not have standard guidelines or recommendations on the use of sedation-analgesia in patients with drug addiction problems or who are prone to have addiction potential."
			}
		],
		"id": "5149f494d24251bc0500004c",
	},
	{
		"body": "Does the Oncotype DX test work with paraffin embedded tissues?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24103217"
			"http://www.ncbi.nlm.nih.gov/pubmed/23505515"
			"http://www.ncbi.nlm.nih.gov/pubmed/21479927"
			"http://www.ncbi.nlm.nih.gov/pubmed/21370017"
			"http://www.ncbi.nlm.nih.gov/pubmed/19546609"
			"http://www.ncbi.nlm.nih.gov/pubmed/18515733"
			"http://www.ncbi.nlm.nih.gov/pubmed/17463177"
		],
		"triples": [
		],
		"id": "514a0f0ad24251bc05000052",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24103217"
				"endSection": "sections.0"
				"offsetInBeginSection": "2618"
				"offsetInEndSection": "2829"
				"text": "In order to impact clinical decision-making at the time of diagnosis, the Oncotype DX Prostate Cancer Assay was specifically designed for analysis of fixed, paraffin-embedded (FPE) prostate needle biopsy tissue."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23505515"
				"endSection": "sections.0"
				"offsetInBeginSection": "3077"
				"offsetInEndSection": "3326"
				"text": "The performance of the EndoPredict assay in decentralized testing using formalin-fixed, paraffin-embedded (FFPE) tumor tissue was successfully shown in seven European pathology institutions reaching 100% concordance between the different sites [19]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24103217"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "189"
				"text": "Background
Prostate cancer is one of the most common malignancies in men with an estimated 250,000 new cases being diagnosed in the US in 2012, mostly as a consequence of PSA screening [1]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24103217"
				"endSection": "sections.0"
				"offsetInBeginSection": "190"
				"offsetInEndSection": "452"
				"text": "Given that most newly diagnosed cases represent low-risk disease, with less that 3% of men dying of prostate cancer, active surveillance rather than immediate treatment has been broadly endorsed by practice guidelines to be a valid treatment option for many men."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24103217"
				"endSection": "sections.0"
				"offsetInBeginSection": "453"
				"offsetInEndSection": "818"
				"text": "Nonetheless, a large majority of men with low-risk, early stage disease still undergo aggressive intervention with radical prostatectomy and/or radiation therapy [2], despite their attendant long-term side effects and cost, in large part because clinicians are uncertain as to the accuracy of conventional methods for discriminating low-risk from high-risk disease."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24103217"
				"endSection": "sections.0"
				"offsetInBeginSection": "819"
				"offsetInEndSection": "1072"
				"text": "A number of risk assessment tools (e.g. nomograms), based on clinical and pathologic features such as serum PSA level, clinical stage and biopsy Gleason Score, are currently being used for risk stratification of men with early-stage prostate cancer [3]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24103217"
				"endSection": "sections.0"
				"offsetInBeginSection": "1073"
				"offsetInEndSection": "1249"
				"text": "Although these tools have some predictive value, a substantial fraction of men expected to have low-risk disease are found to have more aggressive disease at prostatectomy [4]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24103217"
				"endSection": "sections.0"
				"offsetInBeginSection": "1250"
				"offsetInEndSection": "1385"
				"text": "Clearly there is a need for more accurate discrimination of low risk disease from aggressive prostate cancers at the time of diagnosis."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24103217"
				"endSection": "sections.0"
				"offsetInBeginSection": "1386"
				"offsetInEndSection": "1549"
				"text": "There is a growing recognition that molecular biomarkers can complement conventional clinical and pathologic parameters to personalize the care of cancer patients."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24103217"
				"endSection": "sections.0"
				"offsetInBeginSection": "1550"
				"offsetInEndSection": "1678"
				"text": "However, incorporation of biomarkers into standard clinical practice requires a level of validation which is not often achieved."
			}
		],
		"id": "514a0f0ad24251bc05000052",
	},
	{
		"body": "Is depression associated with poor prognosis of brain tumor patients?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/23735702"
			"http://www.ncbi.nlm.nih.gov/pubmed/23646258"
			"http://www.ncbi.nlm.nih.gov/pubmed/23616158"
			"http://www.ncbi.nlm.nih.gov/pubmed/23480214"
			"http://www.ncbi.nlm.nih.gov/pubmed/22911682"
			"http://www.ncbi.nlm.nih.gov/pubmed/22360815"
			"http://www.ncbi.nlm.nih.gov/pubmed/21478187"
			"http://www.ncbi.nlm.nih.gov/pubmed/20706120"
			"http://www.ncbi.nlm.nih.gov/pubmed/20528763"
			"http://www.ncbi.nlm.nih.gov/pubmed/19743518"
			"http://www.ncbi.nlm.nih.gov/pubmed/19513897"
			"http://www.ncbi.nlm.nih.gov/pubmed/18628405"
			"http://www.ncbi.nlm.nih.gov/pubmed/17664480"
			"http://www.ncbi.nlm.nih.gov/pubmed/16989906"
			"http://www.ncbi.nlm.nih.gov/pubmed/16960653"
			"http://www.ncbi.nlm.nih.gov/pubmed/12709669"
			"http://www.ncbi.nlm.nih.gov/pubmed/12066022"
			"http://www.ncbi.nlm.nih.gov/pubmed/7567756"
			"http://www.ncbi.nlm.nih.gov/pubmed/7449721"
		],
		"triples": [
		],
		"id": "514cc8dcd24251bc05000066",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23646258"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "543"
				"text": "INTRODUCTION
Approximately 18,000 patients are diagnosed with malignant primary brain tumors (PBTs) annually in the United States.[24] Glioblastoma multiforme (GBM) represents the most common malignant brain tumor in adults.[24] Patients with GBM have a poor median survival of one year despite surgical resection followed by radiation with or without concurrent chemotherapy.[2942]
Maintaining a good QOL becomes an important outcome priority in patients with malignant brain tumors whose survival is limited by tumor resistance to treatment."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23646258"
				"endSection": "sections.0"
				"offsetInBeginSection": "3726"
				"offsetInEndSection": "4068"
				"text": "We also examined the QOL measures over time as related to tumor progression, whether the QOL measures were predictive of the outcome, and explored which items of the QOL measures may be predictive of radiological progression by comparing the questionnaire responses from patients who experienced a brain tumor recurrence to those who did not."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23646258"
				"endSection": "sections.0"
				"offsetInBeginSection": "3413"
				"offsetInEndSection": "3563"
				"text": "Questionnaire responses were compared between two groups: Patients with tumor recurrence and/or tumor-related death and patients without a recurrence."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23646258"
				"endSection": "sections.0"
				"offsetInBeginSection": "2228"
				"offsetInEndSection": "2821"
				"text": "The components of the HRQOL may represent independent predictors of survival and may be beneficial when used clinically to make treatment decisions.[7] Several studies in the literature on PBT have focused on the role of specific facets that may serve as significant prognostic factors of survival such as gender, cognitive and social functioning, depression, tumor location, and histological classification.[16193336] We have designed a study to attempt to determine which items of the EORTC QOL measures may be significant predictors of tumor progression on magnetic resonance imaging (MRI)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23646258"
				"endSection": "sections.0"
				"offsetInBeginSection": "2967"
				"offsetInEndSection": "3412"
				"text": "We conducted a prospective longitudinal study of collecting QOL measures using the European Organization and Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30), the associated EORTC Brain Cancer module BN20 (EORTC QLQ-BN20), and Hospital Anxiety and Depression Scale [HADS]) coupled with clinical standards of care (brain MRI, clinical history, and physical examinations) in patients with newly diagnosed PBT."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22911682"
				"endSection": "sections.0"
				"offsetInBeginSection": "3214"
				"offsetInEndSection": "3377"
				"text": "In this study, we hypothesized that genetic variants located within the SLC6A4, BDNF, and AVPR1B genes are associated with prognosis in colorectal cancer patients."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22911682"
				"endSection": "sections.0"
				"offsetInBeginSection": "2533"
				"offsetInEndSection": "2726"
				"text": "The BDNF gene codes for a protein (brain-derived neurotrophic factor) involved in survival, growth, and differentiation of neurons [11], and, like SLC6A4, is involved in the response to stress."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22911682"
				"endSection": "sections.0"
				"offsetInBeginSection": "2083"
				"offsetInEndSection": "2196"
				"text": "Serotonin is a neurotransmitter, deficiency of which leads to clinical depression in susceptible individuals [8]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22911682"
				"endSection": "sections.0"
				"offsetInBeginSection": "1098"
				"offsetInEndSection": "1229"
				"text": "These challenges often surface as depression or anxiety in cancer patients, which are observed in up to 50% of cancer patients [4]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22911682"
				"endSection": "sections.0"
				"offsetInBeginSection": "3037"
				"offsetInEndSection": "3213"
				"text": "Functional and epidemiological studies have shown that this gene and its ligand vasopressin are also linked to anxiety and depression in humans and in model species [15], [16]."
			}
		],
		"id": "514cc8dcd24251bc05000066",
	},
	{
		"body": "What is known about the reimbursement of Viagra",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24327269"
			"http://www.ncbi.nlm.nih.gov/pubmed/24326129"
			"http://www.ncbi.nlm.nih.gov/pubmed/24325699"
			"http://www.ncbi.nlm.nih.gov/pubmed/24323200"
			"http://www.ncbi.nlm.nih.gov/pubmed/24322988"
			"http://www.ncbi.nlm.nih.gov/pubmed/24321784"
			"http://www.ncbi.nlm.nih.gov/pubmed/24320994"
			"http://www.ncbi.nlm.nih.gov/pubmed/24319909"
			"http://www.ncbi.nlm.nih.gov/pubmed/24319241"
			"http://www.ncbi.nlm.nih.gov/pubmed/24317098"
			"http://www.ncbi.nlm.nih.gov/pubmed/24316791"
			"http://www.ncbi.nlm.nih.gov/pubmed/24316779"
			"http://www.ncbi.nlm.nih.gov/pubmed/24316618"
			"http://www.ncbi.nlm.nih.gov/pubmed/24315406"
			"http://www.ncbi.nlm.nih.gov/pubmed/24315212"
			"http://www.ncbi.nlm.nih.gov/pubmed/24314625"
			"http://www.ncbi.nlm.nih.gov/pubmed/24314624"
			"http://www.ncbi.nlm.nih.gov/pubmed/24314622"
			"http://www.ncbi.nlm.nih.gov/pubmed/24313437"
			"http://www.ncbi.nlm.nih.gov/pubmed/24310378"
			"http://www.ncbi.nlm.nih.gov/pubmed/24308304"
			"http://www.ncbi.nlm.nih.gov/pubmed/24307259"
			"http://www.ncbi.nlm.nih.gov/pubmed/24306140"
			"http://www.ncbi.nlm.nih.gov/pubmed/24304157"
			"http://www.ncbi.nlm.nih.gov/pubmed/24303636"
			"http://www.ncbi.nlm.nih.gov/pubmed/24303635"
			"http://www.ncbi.nlm.nih.gov/pubmed/24289845"
			"http://www.ncbi.nlm.nih.gov/pubmed/24303543"
			"http://www.ncbi.nlm.nih.gov/pubmed/24301393"
		],
		"triples": [
		],
		"id": "5150b45ad24251bc0500006f",
	},
		"triples": [
		],
		"id": "5150b45ad24251bc0500006f",
	},
	{
		"body": "Does HER2 under-expression lead to favorable response to trastuzumab?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24323591"
			"http://www.ncbi.nlm.nih.gov/pubmed/24323026"
			"http://www.ncbi.nlm.nih.gov/pubmed/24311954"
			"http://www.ncbi.nlm.nih.gov/pubmed/24311521"
			"http://www.ncbi.nlm.nih.gov/pubmed/24311197"
			"http://www.ncbi.nlm.nih.gov/pubmed/24308017"
			"http://www.ncbi.nlm.nih.gov/pubmed/24306808"
			"http://www.ncbi.nlm.nih.gov/pubmed/24304724"
			"http://www.ncbi.nlm.nih.gov/pubmed/24300914"
			"http://www.ncbi.nlm.nih.gov/pubmed/24298071"
			"http://www.ncbi.nlm.nih.gov/pubmed/24297508"
			"http://www.ncbi.nlm.nih.gov/pubmed/24294514"
			"http://www.ncbi.nlm.nih.gov/pubmed/24286315"
			"http://www.ncbi.nlm.nih.gov/pubmed/24278211"
			"http://www.ncbi.nlm.nih.gov/pubmed/24273914"
			"http://www.ncbi.nlm.nih.gov/pubmed/24273046"
			"http://www.ncbi.nlm.nih.gov/pubmed/24270750"
			"http://www.ncbi.nlm.nih.gov/pubmed/24262440"
			"http://www.ncbi.nlm.nih.gov/pubmed/24261318"
			"http://www.ncbi.nlm.nih.gov/pubmed/24260051"
			"http://www.ncbi.nlm.nih.gov/pubmed/24257305"
			"http://www.ncbi.nlm.nih.gov/pubmed/24255707"
			"http://www.ncbi.nlm.nih.gov/pubmed/24253810"
			"http://www.ncbi.nlm.nih.gov/pubmed/24252402"
			"http://www.ncbi.nlm.nih.gov/pubmed/24251561"
			"http://www.ncbi.nlm.nih.gov/pubmed/24250610"
			"http://www.ncbi.nlm.nih.gov/pubmed/24249715"
			"http://www.ncbi.nlm.nih.gov/pubmed/24248687"
			"http://www.ncbi.nlm.nih.gov/pubmed/24244671"
		],
		"triples": [
		],
		"id": "51542eacd24251bc05000084",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24255707"
				"endSection": "sections.0"
				"offsetInBeginSection": "5025"
				"offsetInEndSection": "5122"
				"text": "We also evaluated serum cMLC1 level as potential biomarker of trastuzumab-induced cardiotoxicity."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24255707"
				"endSection": "sections.0"
				"offsetInBeginSection": "4521"
				"offsetInEndSection": "4669"
				"text": "Riccio, G et al have shown that trastuzumab binds to mouse HER2 and that mice treated with trastuzumab have reduced LVEF in their mouse models [25]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24255707"
				"endSection": "sections.0"
				"offsetInBeginSection": "3889"
				"offsetInEndSection": "4023"
				"text": "Biomarkers of trastuzumab-induced cardiotoxicity are needed for earlier detection and better management of critical early alterations."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24255707"
				"endSection": "sections.0"
				"offsetInBeginSection": "3583"
				"offsetInEndSection": "3710"
				"text": "Based on the extent of LVEF reduction, a decision regarding continuation or discontinuation of trastuzumab therapy is made [9]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24255707"
				"endSection": "sections.0"
				"offsetInBeginSection": "2301"
				"offsetInEndSection": "2536"
				"text": "This study revealed that troponin-I elevation occurred after initiation of trastuzumab in most patients, with subsequent trastuzumab-induced cardiotoxicity occurring one to eight months from the date of the first detectable troponin-I."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24250610"
				"endSection": "sections.0"
				"offsetInBeginSection": "2714"
				"offsetInEndSection": "2860"
				"text": "The conjugate can be alternatively used in the production of therapeutic radionuclides after positive SPECT imaging using [67Ga]-DOTA-trastuzumab."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24255707"
				"endSection": "sections.0"
				"offsetInBeginSection": "2839"
				"offsetInEndSection": "2972"
				"text": "Unfortunately, there are no validated specific biomarkers for clinical use for early detection of trastuzumab-induced cardiotoxicity."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24255707"
				"endSection": "sections.0"
				"offsetInBeginSection": "394"
				"offsetInEndSection": "493"
				"text": "However, both anthracyclines and trastuzumab are associated with considerable cardiotoxicity [5-7]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24255707"
				"endSection": "sections.0"
				"offsetInBeginSection": "4671"
				"offsetInEndSection": "5024"
				"text": "In this study, using echocardiography and electron microscopy, we aimed to evaluate the functional and ultrastructural consequences of trastuzumab treatment in mice, and by using microarray, the effects of trastuzumab on the expression of myocardial genes critically involved in cardiac and mitochondrial functions, adaptation to stress, and DNA repair."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24255707"
				"endSection": "sections.0"
				"offsetInBeginSection": "2537"
				"offsetInEndSection": "2656"
				"text": "This suggests that the intrinsic cardiotoxicity of trastuzumab is a problem and results in cardiomyocyte necrosis [12]."
			}
		],
		"id": "51542eacd24251bc05000084",
	},
	{
		"body": "Can Alzheimer's disease related miRNAs be detected in patients' blood?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24157723"
			"http://www.ncbi.nlm.nih.gov/pubmed/24139697"
			"http://www.ncbi.nlm.nih.gov/pubmed/24064186"
			"http://www.ncbi.nlm.nih.gov/pubmed/23962497"
			"http://www.ncbi.nlm.nih.gov/pubmed/23922807"
			"http://www.ncbi.nlm.nih.gov/pubmed/23895045"
			"http://www.ncbi.nlm.nih.gov/pubmed/23822153"
			"http://www.ncbi.nlm.nih.gov/pubmed/23790110"
			"http://www.ncbi.nlm.nih.gov/pubmed/23528227"
			"http://www.ncbi.nlm.nih.gov/pubmed/23435408"
			"http://www.ncbi.nlm.nih.gov/pubmed/23241907"
			"http://www.ncbi.nlm.nih.gov/pubmed/23054683"
			"http://www.ncbi.nlm.nih.gov/pubmed/23026534"
			"http://www.ncbi.nlm.nih.gov/pubmed/22155483"
			"http://www.ncbi.nlm.nih.gov/pubmed/21709374"
			"http://www.ncbi.nlm.nih.gov/pubmed/21548758"
			"http://www.ncbi.nlm.nih.gov/pubmed/20451875"
			"http://www.ncbi.nlm.nih.gov/pubmed/20380821"
			"http://www.ncbi.nlm.nih.gov/pubmed/19923886"
			"http://www.ncbi.nlm.nih.gov/pubmed/19625741"
			"http://www.ncbi.nlm.nih.gov/pubmed/19936094"
		],
		"triples": [
		],
		"id": "5156beb4d24251bc05000089",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23241907"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "242"
				"text": "Alzheimer's disease represents a major, and increasing, health care problem, the recognition of which led to the passage of the National Alzheimer's Project Act in 2011 and the creation of the first national plan for Alzheimer's disease (AD)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23922807"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "138"
				"text": "Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative disease manifested by dementia typically observed in the elderly."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23922807"
				"endSection": "sections.0"
				"offsetInBeginSection": "7495"
				"offsetInEndSection": "7610"
				"text": "Their role is not limited to a diagnostic viewpoint, but also provides a further understanding of disease etiology."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23922807"
				"endSection": "sections.0"
				"offsetInBeginSection": "4327"
				"offsetInEndSection": "4541"
				"text": "There have been multiple reports of plasma/serum markers identified, which could potentially distinguish various neurodegenerative conditions including AD [19], Parkinson's disease (PD) [20] and schizophrenia [21]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23895045"
				"endSection": "sections.0"
				"offsetInBeginSection": "2813"
				"offsetInEndSection": "2906"
				"text": "Several blood, plasma, or serum born AD biomarkers have been proposed to meet these criteria."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23895045"
				"endSection": "sections.0"
				"offsetInBeginSection": "3022"
				"offsetInEndSection": "3136"
				"text": "Moreover, Tan et al. provided evidence that the proteins p53 and p21 can be used to detect AD using blood samples."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23922807"
				"endSection": "sections.0"
				"offsetInBeginSection": "4078"
				"offsetInEndSection": "4193"
				"text": "An advantage of using blood-based markers is the ease and possible frequency of collection of sample from patients."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23922807"
				"endSection": "sections.0"
				"offsetInBeginSection": "7059"
				"offsetInEndSection": "7261"
				"text": "Circulating profiles of miRNAs have been shown to discriminate different tumor types, [40][41],[42][43][44] indicate staging and progression of the disease [45] and serve as prognostic markers [46][47]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23895045"
				"endSection": "sections.0"
				"offsetInBeginSection": "4597"
				"offsetInEndSection": "4921"
				"text": "Patient blood was obtained from the SAMPLE (Serial Alzheimer diseaseand MCI Prospective Longitudinal Evaluation) Registry of PrecisionMed (San Diego, CA, USA) and blood from age-matched healthy donors from the ACE (Aging Cognition Evaluation) Registry, a PrecisionMed- UBC (The University of British Columbia) collaboration."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23922807"
				"endSection": "sections.0"
				"offsetInBeginSection": "3914"
				"offsetInEndSection": "4077"
				"text": "Another source of biomarkers that has been the focus of attention of researchers, especially in cancer biology and cardiovascular diseases is blood [16]
[17]
[18]."
			}
		],
		"id": "5156beb4d24251bc05000089",
	},
	{
		"body": "Which antiepileptic drug is most strongly associated with spina bifida?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24078478"
			"http://www.ncbi.nlm.nih.gov/pubmed/23911758"
			"http://www.ncbi.nlm.nih.gov/pubmed/23911754"
			"http://www.ncbi.nlm.nih.gov/pubmed/23461556"
			"http://www.ncbi.nlm.nih.gov/pubmed/23318894"
			"http://www.ncbi.nlm.nih.gov/pubmed/22051200"
			"http://www.ncbi.nlm.nih.gov/pubmed/21768370"
			"http://www.ncbi.nlm.nih.gov/pubmed/21766433"
			"http://www.ncbi.nlm.nih.gov/pubmed/21247222"
			"http://www.ncbi.nlm.nih.gov/pubmed/21127116"
			"http://www.ncbi.nlm.nih.gov/pubmed/20680999"
			"http://www.ncbi.nlm.nih.gov/pubmed/20558369"
			"http://www.ncbi.nlm.nih.gov/pubmed/19490988"
			"http://www.ncbi.nlm.nih.gov/pubmed/19490036"
			"http://www.ncbi.nlm.nih.gov/pubmed/18929082"
			"http://www.ncbi.nlm.nih.gov/pubmed/18477081"
			"http://www.ncbi.nlm.nih.gov/pubmed/18448870"
			"http://www.ncbi.nlm.nih.gov/pubmed/18251369"
			"http://www.ncbi.nlm.nih.gov/pubmed/17448293"
			"http://www.ncbi.nlm.nih.gov/pubmed/17315493"
			"http://www.ncbi.nlm.nih.gov/pubmed/17075842"
			"http://www.ncbi.nlm.nih.gov/pubmed/16933125"
			"http://www.ncbi.nlm.nih.gov/pubmed/16639967"
			"http://www.ncbi.nlm.nih.gov/pubmed/16430419"
			"http://www.ncbi.nlm.nih.gov/pubmed/16417040"
			"http://www.ncbi.nlm.nih.gov/pubmed/16280367"
			"http://www.ncbi.nlm.nih.gov/pubmed/15955936"
			"http://www.ncbi.nlm.nih.gov/pubmed/15901671"
			"http://www.ncbi.nlm.nih.gov/pubmed/15847033"
		],
		"triples": [
		],
		"id": "51588bb2d24251bc05000091",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21127116"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "122"
				"text": "Introduction
Carbamazepine is one of the most commonly used antiepileptic drugs in Europe among women of childbearing age."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21127116"
				"endSection": "sections.0"
				"offsetInBeginSection": "123"
				"offsetInEndSection": "1019"
				"text": "Several cohort studies have evaluated the risk of major congenital malformations associated with carbamazepine, and it seemed to be less teratogenic than valproic acid.1 2 3 4 5 6 Although around 3000 pregnancies with recorded carbamazepine exposure have been described in the literature, each individual study on its own is too small to have the statistical power to detect risks for specific congenital malformations compared with other antiepileptic drugs.4 7 8
The EUROCAT (European Surveillance of Congenital Anomalies) Antiepileptic Study Database, which was set up for a study of lamotrigine, covered 3 881 592 births and contains 131 registrations of malformation in pregnancy outcomes exposed to carbamazepine monotherapy, more than in any other published study.9 This enabled the examination of risks of specific major congenital malformations associated with carbamazepine monotherapy."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21127116"
				"endSection": "sections.0"
				"offsetInBeginSection": "1020"
				"offsetInEndSection": "1232"
				"text": "We reviewed and combined studies on carbamazepine to identify indications of increased risks of specific malformations after intrauterine exposure to carbamazepine monotherapy in the first trimester of pregnancy."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21127116"
				"endSection": "sections.0"
				"offsetInBeginSection": "1233"
				"offsetInEndSection": "1349"
				"text": "We tested these indications, or prior hypotheses, in a case-control study using two control groups of malformations."
			}
		],
		"id": "51588bb2d24251bc05000091",
	},
	{
		"body": "Where in the cell do we find the protein Cep135?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/23864714"
			"http://www.ncbi.nlm.nih.gov/pubmed/23810536"
			"http://www.ncbi.nlm.nih.gov/pubmed/23511974"
			"http://www.ncbi.nlm.nih.gov/pubmed/23456457"
			"http://www.ncbi.nlm.nih.gov/pubmed/23213374"
			"http://www.ncbi.nlm.nih.gov/pubmed/23115304"
			"http://www.ncbi.nlm.nih.gov/pubmed/22976301"
			"http://www.ncbi.nlm.nih.gov/pubmed/22898782"
			"http://www.ncbi.nlm.nih.gov/pubmed/22521416"
			"http://www.ncbi.nlm.nih.gov/pubmed/22349705"
			"http://www.ncbi.nlm.nih.gov/pubmed/22261722"
			"http://www.ncbi.nlm.nih.gov/pubmed/21766470"
			"http://www.ncbi.nlm.nih.gov/pubmed/20516151"
			"http://www.ncbi.nlm.nih.gov/pubmed/20392737"
			"http://www.ncbi.nlm.nih.gov/pubmed/19454482"
			"http://www.ncbi.nlm.nih.gov/pubmed/19321663"
			"http://www.ncbi.nlm.nih.gov/pubmed/19293139"
			"http://www.ncbi.nlm.nih.gov/pubmed/18851962"
			"http://www.ncbi.nlm.nih.gov/pubmed/17681131"
			"http://www.ncbi.nlm.nih.gov/pubmed/16240430"
			"http://www.ncbi.nlm.nih.gov/pubmed/14983524"
			"http://www.ncbi.nlm.nih.gov/pubmed/11781336"
			"http://www.ncbi.nlm.nih.gov/pubmed/10842375"
		],
		"triples": [
		],
		"id": "51596a8ad24251bc0500009e",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/11781336"
				"endSection": "sections.0"
				"offsetInBeginSection": "1064"
				"offsetInEndSection": "1199"
				"text": "In addition, the centrosome is known to act as a cell center, attracting a number of other noncentrosomal molecules into and around it."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23213374"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "283"
				"text": "Introduction
Centrioles and basal bodies are closely related barrel-shaped structures that function in the formation of centrosomes and the assembly of cilia and flagella, respectively (Bettencourt-Dias and Glover, 2007; Bornens, 2012; Lüders and Stearns, 2007; Nigg and Raff, 2009)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23213374"
				"endSection": "sections.0"
				"offsetInBeginSection": "284"
				"offsetInEndSection": "505"
				"text": "In human cells, centriole cylinders are built of nine triplet microtubules (MTs) and have approximate diameters of 150–200 nm and lengths of 400–450 nm (Bornens, 2012; Paintrand et al., 1992; Vorobjev and Chentsov, 1980)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23213374"
				"endSection": "sections.0"
				"offsetInBeginSection": "506"
				"offsetInEndSection": "700"
				"text": "Each centrosome comprises two centrioles that are surrounded by an amorphous protein cloud, the pericentriolar material (PCM) (Bornens, 2002; Chrétien et al., 1997; Vorobjev and Chentsov, 1980)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23213374"
				"endSection": "sections.0"
				"offsetInBeginSection": "701"
				"offsetInEndSection": "841"
				"text": "As indicated by proteomics analyses, the PCM is composed of more than 100 different proteins (Andersen et al., 2003; Jakobsen et al., 2011)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23213374"
				"endSection": "sections.0"
				"offsetInBeginSection": "842"
				"offsetInEndSection": "1080"
				"text": "Of the two centrioles, the older one (frequently referred to as the mother) carries distinctive distal and subdistal appendages (Paintrand et al., 1992), which confer important functional asymmetry (Bornens, 2012; Nigg and Stearns, 2011)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23213374"
				"endSection": "sections.0"
				"offsetInBeginSection": "1081"
				"offsetInEndSection": "1236"
				"text": "In dividing cells, centrosomes organize the microtubule cytoskeleton throughout interphase and they assist in the formation of bipolar spindles in mitosis."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23213374"
				"endSection": "sections.0"
				"offsetInBeginSection": "1237"
				"offsetInEndSection": "1350"
				"text": "In differentiated cells, basal bodies form either de novo or from the oldest, appendage-bearing mother centriole."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23213374"
				"endSection": "sections.0"
				"offsetInBeginSection": "1351"
				"offsetInEndSection": "1572"
				"text": "These then serve as platforms for the formation of motile and immotile cilia that are essential for development and health of the organism (Bettencourt-Dias et al., 2011; Ishikawa and Marshall, 2011; Nigg and Raff, 2009)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23213374"
				"endSection": "sections.0"
				"offsetInBeginSection": "1573"
				"offsetInEndSection": "1880"
				"text": "In recent years, much progress has been made towards assembling a parts list of human centrosomes and key proteins important for centriole biogenesis, duplication, PCM recruitment and basal body functions have been identified (Carvalho-Santos et al., 2011; Dobbelaere et al., 2008; Strnad and Gönczy, 2008)."
			}
		],
		"id": "51596a8ad24251bc0500009e",
	},
	{
		"body": "In which isochores are Alu elements enriched?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/22057813"
			"http://www.ncbi.nlm.nih.gov/pubmed/19543403"
			"http://www.ncbi.nlm.nih.gov/pubmed/16551647"
			"http://www.ncbi.nlm.nih.gov/pubmed/15871047"
			"http://www.ncbi.nlm.nih.gov/pubmed/14575716"
			"http://www.ncbi.nlm.nih.gov/pubmed/12654999"
			"http://www.ncbi.nlm.nih.gov/pubmed/12468093"
			"http://www.ncbi.nlm.nih.gov/pubmed/11591470"
			"http://www.ncbi.nlm.nih.gov/pubmed/9931467"
			"http://www.ncbi.nlm.nih.gov/pubmed/7723057"
			"http://www.ncbi.nlm.nih.gov/pubmed/8276253"
			"http://www.ncbi.nlm.nih.gov/pubmed/6572942"
		],
		"triples": [
		],
		"id": "515bd543298dcd4e51000001",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "2844"
				"offsetInEndSection": "2994"
				"text": "Focusing on chromosomes 17–22 is justified by considering that these chromosomes are representative, in terms of isochores, of the whole human genome."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "2679"
				"offsetInEndSection": "2843"
				"text": "We thought that our approach was acceptable in view of the fact that our primary aim was to look for the localization of insertions/deletions and SNPs on isochores."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "522"
				"offsetInEndSection": "1622"
				"text": "The three main reasons for carrying out this investigation were the following: (i) to localize insertions, deletions and SNPs on chromosomes 17 to 22, in connection with the compartmentalization of the human genome into isochores [6], [7]; this was done at two levels, namely localization in isochore families (L1, L2, H1, H2, H3, in order of increasing GC and gene density) and mapping within the isochores; (ii) to correlate insertions, deletions and SNPs with the densities of genes, interspersed repeats and retroviral insertions, since these densities are correlated, in turn, with isochore GC levels [8]–[12], [6], and since they may provide indications for the preference of insertions/deletions for different isochore families; (iii) to prepare the ground for exploring the expression of genes located in the neighborhood of deletions and insertions; indeed it has been postulated [7] that compositional changes due to the accumulation of AT-biased point mutations or to deletions/insertions may be associated with alterations of chromatin structure that, in turn, may affect gene expression."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "244"
				"text": "Introduction
The very recent availability of fully sequenced individual human genomes [1]–[5] is a major revolution in biology which is certainly going to provide new insights into genetic diseases and genomic rearrangements in the near future."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "245"
				"offsetInEndSection": "521"
				"text": "In the present work, we looked at the insertions, deletions and SNPs that are present in Craig Venter's genome [1], more precisely on chromosomes 17 to 22 (334 megabases, about 10% of the human genome), and compared them with the human reference genome hg17 from UCSC website."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "1623"
				"offsetInEndSection": "1916"
				"text": "It should be pointed out that the present work only concerns (i) insertions and deletions among structural variations (not including copy-number variations such as segmental duplications; see ref. [13] for a review, and ref. [14]); and (ii) SNPs as detected by pairwise alignment of sequences."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "1917"
				"offsetInEndSection": "2130"
				"text": "It should also be stressed that the Venter genome used in our comparison, represents a composite haploid version of the genome where the highest scoring alleles contained are represented in the consensus sequence."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "2131"
				"offsetInEndSection": "2311"
				"text": "The human reference genome hg17 (practically identical to the latest hg18 version for the chromosomes under consideration) is a composite genome resulting from several individuals."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "2312"
				"offsetInEndSection": "2491"
				"text": "Insertions and deletions, as well as SNPs, reported in this article are, therefore, the result of the comparison of one genome, the Venter genome, with several individual genomes."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/19543403"
				"endSection": "sections.0"
				"offsetInBeginSection": "2492"
				"offsetInEndSection": "2640"
				"text": "In other words, each insertion and deletion in Venter is derived from a comparison with another individual, but not necessarily the same individual."
			}
		],
		"id": "515bd543298dcd4e51000001",
	},
	{
		"body": "Which forms of cancer is the Tpl2 gene associated with?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24265246"
			"http://www.ncbi.nlm.nih.gov/pubmed/24188160"
			"http://www.ncbi.nlm.nih.gov/pubmed/24067898"
			"http://www.ncbi.nlm.nih.gov/pubmed/23982215"
			"http://www.ncbi.nlm.nih.gov/pubmed/23533274"
			"http://www.ncbi.nlm.nih.gov/pubmed/23457529"
			"http://www.ncbi.nlm.nih.gov/pubmed/23125217"
			"http://www.ncbi.nlm.nih.gov/pubmed/22451924"
			"http://www.ncbi.nlm.nih.gov/pubmed/21267413"
			"http://www.ncbi.nlm.nih.gov/pubmed/21107320"
			"http://www.ncbi.nlm.nih.gov/pubmed/20227498"
			"http://www.ncbi.nlm.nih.gov/pubmed/20045951"
			"http://www.ncbi.nlm.nih.gov/pubmed/19808956"
			"http://www.ncbi.nlm.nih.gov/pubmed/19159680"
			"http://www.ncbi.nlm.nih.gov/pubmed/19054068"
			"http://www.ncbi.nlm.nih.gov/pubmed/18339866"
			"http://www.ncbi.nlm.nih.gov/pubmed/16565081"
			"http://www.ncbi.nlm.nih.gov/pubmed/15575964"
			"http://www.ncbi.nlm.nih.gov/pubmed/15372110"
			"http://www.ncbi.nlm.nih.gov/pubmed/12234923"
			"http://www.ncbi.nlm.nih.gov/pubmed/11163183"
		],
		"triples": [
		],
		"id": "515bf6d6298dcd4e51000004",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23457529"
				"endSection": "sections.0"
				"offsetInBeginSection": "2771"
				"offsetInEndSection": "2954"
				"text": "Therefore, the role of Tpl2 in tumorigenesis is complex, as either overexpression or reduced expression of this gene can promote a tumorigenic state depending on the cancer type [17]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23457529"
				"endSection": "sections.0"
				"offsetInBeginSection": "1420"
				"offsetInEndSection": "1569"
				"text": "The Tpl2/MAP3k8 gene was first isolated from thyroid tumors as a gene capable of inducing morphological transformation of NIH3T3 and SHOK cells [11]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21267413"
				"endSection": "sections.0"
				"offsetInBeginSection": "301"
				"offsetInEndSection": "396"
				"text": "However, once the cancer spreads beyond the prostate gland, the outcome is nearly always fatal."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21267413"
				"endSection": "sections.0"
				"offsetInBeginSection": "3917"
				"offsetInEndSection": "4141"
				"text": "Furthermore, the suppression of TPL2 diminishes ADI prostate cancer growth and a high frequency of TPL2 overexpression in human ADI prostate cancer samples validates TPL2 as a target for the treatment of this deadly disease."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21267413"
				"endSection": "sections.0"
				"offsetInBeginSection": "397"
				"offsetInEndSection": "667"
				"text": "Since prostate cancer cells require testosterone to fuel their growth and survival, androgen-deprivation therapy has been designed to halt cancer growth by either stopping the production of testosterone or preventing the hormone from acting on prostate cancer cells [2]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21267413"
				"endSection": "sections.0"
				"offsetInBeginSection": "118"
				"offsetInEndSection": "300"
				"text": "Surgery is effective, with nearly 100% of the patients remaining cancer-free for several years if the disease is detected early and the cancer cells are confined to the prostate [1]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23457529"
				"endSection": "sections.0"
				"offsetInBeginSection": "2955"
				"offsetInEndSection": "3083"
				"text": "Numerous reports suggest inflammation in the microenvironment contributes to the development or progression of skin cancer [20]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21267413"
				"endSection": "sections.0"
				"offsetInBeginSection": "1101"
				"offsetInEndSection": "1247"
				"text": "This lack of understanding hampers our ability to develop target-driven therapeutic strategies for the efficient treatment of ADI prostate cancer."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21267413"
				"endSection": "sections.0"
				"offsetInBeginSection": "1708"
				"offsetInEndSection": "1863"
				"text": "Therefore, under androgen-depleted conditions, ADI prostate cancer cells appear to develop intracellular strategies that activate the AR signaling pathway."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/21267413"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "117"
				"text": "Introduction
Prostate cancer affects 1 in 6 American men, with more than 2 million currently living with the disease."
			}
		],
		"id": "515bf6d6298dcd4e51000004",
	},
	{
		"body": "What is the INSURE procedure in premature babies.",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24075206"
			"http://www.ncbi.nlm.nih.gov/pubmed/23808250"
			"http://www.ncbi.nlm.nih.gov/pubmed/23612264"
			"http://www.ncbi.nlm.nih.gov/pubmed/23336160"
			"http://www.ncbi.nlm.nih.gov/pubmed/23235135"
			"http://www.ncbi.nlm.nih.gov/pubmed/22954263"
			"http://www.ncbi.nlm.nih.gov/pubmed/22430447"
			"http://www.ncbi.nlm.nih.gov/pubmed/22266202"
			"http://www.ncbi.nlm.nih.gov/pubmed/21815280"
			"http://www.ncbi.nlm.nih.gov/pubmed/21506654"
			"http://www.ncbi.nlm.nih.gov/pubmed/21089712"
			"http://www.ncbi.nlm.nih.gov/pubmed/20642659"
			"http://www.ncbi.nlm.nih.gov/pubmed/20616570"
			"http://www.ncbi.nlm.nih.gov/pubmed/20545934"
			"http://www.ncbi.nlm.nih.gov/pubmed/20180736"
			"http://www.ncbi.nlm.nih.gov/pubmed/19679893"
			"http://www.ncbi.nlm.nih.gov/pubmed/19485954"
			"http://www.ncbi.nlm.nih.gov/pubmed/17069738"
			"http://www.ncbi.nlm.nih.gov/pubmed/16549210"
			"http://www.ncbi.nlm.nih.gov/pubmed/10218338"
			"http://www.ncbi.nlm.nih.gov/pubmed/8472042"
		],
		"triples": [
		],
		"id": "515db54c298dcd4e51000016",
	},
		"triples": [
		],
		"id": "515db54c298dcd4e51000016",
	},
	{
		"body": "Which species may be used for the biotechnological production of itaconic acid?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/23889751"
			"http://www.ncbi.nlm.nih.gov/pubmed/23420787"
			"http://www.ncbi.nlm.nih.gov/pubmed/23298766"
			"http://www.ncbi.nlm.nih.gov/pubmed/22956279"
			"http://www.ncbi.nlm.nih.gov/pubmed/22480369"
			"http://www.ncbi.nlm.nih.gov/pubmed/21052988"
			"http://www.ncbi.nlm.nih.gov/pubmed/19629471"
			"http://www.ncbi.nlm.nih.gov/pubmed/11548996"
		],
		"triples": [
		],
		"id": "515ffc2b298dcd4e51000035",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23420787"
				"endSection": "sections.0"
				"offsetInBeginSection": "1639"
				"offsetInEndSection": "1784"
				"text": "The current knowledge about the biotechnological production of itaconic acid was recently reviewed (Willke and Vorlop, 2001; Okabe et al., 2009)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23420787"
				"endSection": "sections.0"
				"offsetInBeginSection": "1157"
				"offsetInEndSection": "1349"
				"text": "Currently, the worldwide production capacity of itaconic acid is expected to be about 50 kt per year, facing a demand of about 30 kt (Shaw, 2013, Itaconix Corporation, personal communication)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23420787"
				"endSection": "sections.0"
				"offsetInBeginSection": "1785"
				"offsetInEndSection": "1890"
				"text": "The latter review covers the industrial production of itaconic acid and the applications of this product."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23889751"
				"endSection": "sections.0"
				"offsetInBeginSection": "3201"
				"offsetInEndSection": "3356"
				"text": "Ustilago maydis shows this high biotechnological potential and is known to produce chemicals such as glycolipids, itaconic, malic or succinic acid [25-29]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22480369"
				"endSection": "sections.0"
				"offsetInBeginSection": "875"
				"offsetInEndSection": "1062"
				"text": "Analogous to other organic acids such as citric acid or lactic acid, itaconic acid is mainly supplied by biotechnological processes with the fungus Aspergillus terreus (A. terreus) [6,7]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22480369"
				"endSection": "sections.0"
				"offsetInBeginSection": "2027"
				"offsetInEndSection": "2109"
				"text": "In 1955, the production of itaconic acid was firstly described for U. maydis [11]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23420787"
				"endSection": "sections.0"
				"offsetInBeginSection": "331"
				"offsetInEndSection": "488"
				"text": "Since the 1960s the production of itaconic acid is achieved by the fermentation with Aspergillus terreus on sugar containing media (Willke and Vorlop, 2001)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23420787"
				"endSection": "sections.0"
				"offsetInBeginSection": "960"
				"offsetInEndSection": "1156"
				"text": "Although the production costs for itaconic acid are declining in the last years ($ 4 per kg in 2001; Willke and Vorlop, 2001), it is still a valuable product with an estimated price of $ 2 per kg."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23420787"
				"endSection": "sections.0"
				"offsetInBeginSection": "2038"
				"offsetInEndSection": "2236"
				"text": "For rational strain improvement, it is essential to understand the underlying biological concepts and biochemical pathways leading to the production of this important organic acid in microorganisms."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23889751"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "202"
				"text": "Background
In recent years, the efficient use of plant biomass, especially non-food lignocellulosic biomass as renewable resource for biotechnological applications has become increasingly important [1]."
			}
		],
		"id": "515ffc2b298dcd4e51000035",
	},
	{
		"body": "What is the role of TRH in hypertension?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24295737"
			"http://www.ncbi.nlm.nih.gov/pubmed/24288596"
			"http://www.ncbi.nlm.nih.gov/pubmed/23931276"
			"http://www.ncbi.nlm.nih.gov/pubmed/21900943"
			"http://www.ncbi.nlm.nih.gov/pubmed/21718733"
			"http://www.ncbi.nlm.nih.gov/pubmed/21135357"
			"http://www.ncbi.nlm.nih.gov/pubmed/17884458"
			"http://www.ncbi.nlm.nih.gov/pubmed/17227965"
			"http://www.ncbi.nlm.nih.gov/pubmed/15837533"
			"http://www.ncbi.nlm.nih.gov/pubmed/12377295"
			"http://www.ncbi.nlm.nih.gov/pubmed/11566956"
			"http://www.ncbi.nlm.nih.gov/pubmed/11230301"
			"http://www.ncbi.nlm.nih.gov/pubmed/8853637"
			"http://www.ncbi.nlm.nih.gov/pubmed/7498977"
			"http://www.ncbi.nlm.nih.gov/pubmed/7554113"
			"http://www.ncbi.nlm.nih.gov/pubmed/8139877"
			"http://www.ncbi.nlm.nih.gov/pubmed/1595355"
			"http://www.ncbi.nlm.nih.gov/pubmed/1667428"
			"http://www.ncbi.nlm.nih.gov/pubmed/1784404"
			"http://www.ncbi.nlm.nih.gov/pubmed/1802392"
			"http://www.ncbi.nlm.nih.gov/pubmed/1681822"
			"http://www.ncbi.nlm.nih.gov/pubmed/2107018"
			"http://www.ncbi.nlm.nih.gov/pubmed/2856652"
			"http://www.ncbi.nlm.nih.gov/pubmed/2854272"
			"http://www.ncbi.nlm.nih.gov/pubmed/3035513"
			"http://www.ncbi.nlm.nih.gov/pubmed/3938843"
			"http://www.ncbi.nlm.nih.gov/pubmed/104513"
			"http://www.ncbi.nlm.nih.gov/pubmed/20256"
		],
		"triples": [
		],
		"id": "51602609298dcd4e5100003a",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "401"
				"offsetInEndSection": "646"
				"text": "Among those most severely affected are persons with treatment resistant hypertension (TRH) who have uncontrolled hypertension (HTN) on ≥3 antihypertensive medication classes or require ≥4 antihypertensive medications to reach their BP goals [2]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "1776"
				"offsetInEndSection": "2038"
				"text": "Therefore, we assessed genetic associations with TRH among African American and white participants in the Genetics of Hypertension Associated Treatment (GenHAT) study using 78 candidate genetic polymorphisms implicated in the development of hypertension and CVD."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "747"
				"offsetInEndSection": "1021"
				"text": "However, some limitations of these estimates in the context of epidemiological studies are noted (e.g., potential misclassification due to BP measuring technique, nonadherence to medication, inadequate dosing, white-coat hypertension, and/or secondary causes of HTN) [3, 4]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "0"
				"offsetInEndSection": "2"
				"text": "1."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "3"
				"offsetInEndSection": "116"
				"text": "Introduction
Multidrug resistance to blood pressure (BP) lowering treatments is a growing problem in the USA [1]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "117"
				"offsetInEndSection": "400"
				"text": "In a recent report based on the National Health and Nutrition Examination Surveys (NHANES) collected in 1998–1994, 1999–2004, and 2005–2008, the percentage of treated uncontrolled patients on monotherapy fell, whereas the percentage on at least 3 medications increased over time [1]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "647"
				"offsetInEndSection": "746"
				"text": "Recently, multiple studies have reported that the prevalence of TRH is 10–20% among those with HTN."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "1022"
				"offsetInEndSection": "1200"
				"text": "Most concerning is the fact that TRH is consistently associated with increased cardiovascular disease (CVD) morbidity and mortality compared to more easily controlled HTN [3, 4]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "1201"
				"offsetInEndSection": "1449"
				"text": "Demonstrated risk factors for TRH include increasing age, diminished kidney function, higher body mass index (BMI), diabetes mellitus (DM), and African American race (e.g., African Americans are approximately twice as likely to be affected [1, 5])."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24288596"
				"endSection": "sections.0"
				"offsetInBeginSection": "1450"
				"offsetInEndSection": "1607"
				"text": "However, these risk factors only partially account for the incidence of TRH, suggesting that other factors, including genetic factors, may increase risk [6]."
			}
		],
		"id": "51602609298dcd4e5100003a",
	},
	{
		"body": "Which histone marks are deposited by Set7?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24129573"
			"http://www.ncbi.nlm.nih.gov/pubmed/24097032"
			"http://www.ncbi.nlm.nih.gov/pubmed/24088713"
			"http://www.ncbi.nlm.nih.gov/pubmed/24019522"
			"http://www.ncbi.nlm.nih.gov/pubmed/23959865"
			"http://www.ncbi.nlm.nih.gov/pubmed/23880568"
			"http://www.ncbi.nlm.nih.gov/pubmed/23873758"
			"http://www.ncbi.nlm.nih.gov/pubmed/23625014"
			"http://www.ncbi.nlm.nih.gov/pubmed/23575530"
			"http://www.ncbi.nlm.nih.gov/pubmed/23519668"
			"http://www.ncbi.nlm.nih.gov/pubmed/23509280"
			"http://www.ncbi.nlm.nih.gov/pubmed/23478572"
			"http://www.ncbi.nlm.nih.gov/pubmed/23478445"
			"http://www.ncbi.nlm.nih.gov/pubmed/23475131"
			"http://www.ncbi.nlm.nih.gov/pubmed/23468428"
			"http://www.ncbi.nlm.nih.gov/pubmed/23462506"
			"http://www.ncbi.nlm.nih.gov/pubmed/23419719"
			"http://www.ncbi.nlm.nih.gov/pubmed/23413810"
			"http://www.ncbi.nlm.nih.gov/pubmed/23345616"
			"http://www.ncbi.nlm.nih.gov/pubmed/23302691"
			"http://www.ncbi.nlm.nih.gov/pubmed/23289424"
			"http://www.ncbi.nlm.nih.gov/pubmed/23249738"
			"http://www.ncbi.nlm.nih.gov/pubmed/23209566"
			"http://www.ncbi.nlm.nih.gov/pubmed/23152447"
			"http://www.ncbi.nlm.nih.gov/pubmed/23028348"
			"http://www.ncbi.nlm.nih.gov/pubmed/23024815"
			"http://www.ncbi.nlm.nih.gov/pubmed/22870396"
			"http://www.ncbi.nlm.nih.gov/pubmed/22772057"
			"http://www.ncbi.nlm.nih.gov/pubmed/22709867"
		],
		"triples": [
		],
		"id": "5160412d298dcd4e5100003c",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23625014"
				"endSection": "sections.0"
				"offsetInBeginSection": "3510"
				"offsetInEndSection": "3613"
				"text": "Specific histone modifications appear to dictate whether or not a KMT can further modify its substrate."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23289424"
				"endSection": "sections.0"
				"offsetInBeginSection": "1493"
				"offsetInEndSection": "1591"
				"text": "Among the five histone families of the chromatosome, the linker histone H1 is the least conserved."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23028348"
				"endSection": "sections.0"
				"offsetInBeginSection": "3453"
				"offsetInEndSection": "3546"
				"text": "Our study implicates the histone modification H4K20me1 in the process of dosage compensation."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23289424"
				"endSection": "sections.0"
				"offsetInBeginSection": "1745"
				"offsetInEndSection": "1863"
				"text": "The study described here focuses on histone H1.4, a histone variant that is expressed in somatic cells during S phase."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23289424"
				"endSection": "sections.0"
				"offsetInBeginSection": "5291"
				"offsetInEndSection": "5450"
				"text": "Whether or not other modifications of the histone code such as methylation or phosphorylation also crosstalk with ADP-ribosylation has not been studied before."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23209566"
				"endSection": "sections.0"
				"offsetInBeginSection": "4033"
				"offsetInEndSection": "4162"
				"text": "We approached this by studying 53BP1 DSB repair function and DSB recruitment in MEFs lacking specific histone methyltransferases."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23289424"
				"endSection": "sections.0"
				"offsetInBeginSection": "1864"
				"offsetInEndSection": "1940"
				"text": "Together with H1.2 it is the predominant histone variant in most cell types."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23625014"
				"endSection": "sections.0"
				"offsetInBeginSection": "501"
				"offsetInEndSection": "827"
				"text": "The access to genetic elements is regulated by various enzymatic activities including histone posttranslational modifications, chromatin remodeling and histone exchange by histone variants that alter the physical properties of the nucleosome or provide alternative sequences for posttranslational modifications and regulation."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23209566"
				"endSection": "sections.0"
				"offsetInBeginSection": "1855"
				"offsetInEndSection": "1993"
				"text": "An earlier study reported that 53BP1 can also be recruited to sites of DSBs by interaction with dimethylated lysine 79 of histone H3 [25]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/23024815"
				"endSection": "sections.0"
				"offsetInBeginSection": "297"
				"offsetInEndSection": "508"
				"text": "It has been proposed that distinct histone modifications, on one or more tails, act sequentially or in combination to form a “histone code” that is read by other proteins to bring about distinct events [4], [5]."
			}
		],
		"id": "5160412d298dcd4e5100003c",
	},
	{
		"body": "Are there any desmins present in plants?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/21929896"
			"http://www.ncbi.nlm.nih.gov/pubmed/20171226"
			"http://www.ncbi.nlm.nih.gov/pubmed/19026658"
			"http://www.ncbi.nlm.nih.gov/pubmed/18472024"
			"http://www.ncbi.nlm.nih.gov/pubmed/18033728"
			"http://www.ncbi.nlm.nih.gov/pubmed/16519886"
			"http://www.ncbi.nlm.nih.gov/pubmed/15560991"
			"http://www.ncbi.nlm.nih.gov/pubmed/12529857"
			"http://www.ncbi.nlm.nih.gov/pubmed/10929203"
			"http://www.ncbi.nlm.nih.gov/pubmed/9925099"
			"http://www.ncbi.nlm.nih.gov/pubmed/8752741"
			"http://www.ncbi.nlm.nih.gov/pubmed/1694790"
			"http://www.ncbi.nlm.nih.gov/pubmed/2659540"
			"http://www.ncbi.nlm.nih.gov/pubmed/7460905"
		],
		"triples": [
		],
		"id": "5162e011298dcd4e51000049",
	},
		"triples": [
		],
		"id": "5162e011298dcd4e51000049",
	},
	{
		"body": "Is it possible to detect survivin protein expression in normal human adult tissues?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24325949"
			"http://www.ncbi.nlm.nih.gov/pubmed/24297644"
			"http://www.ncbi.nlm.nih.gov/pubmed/24294379"
			"http://www.ncbi.nlm.nih.gov/pubmed/24265231"
			"http://www.ncbi.nlm.nih.gov/pubmed/24235270"
			"http://www.ncbi.nlm.nih.gov/pubmed/24233024"
			"http://www.ncbi.nlm.nih.gov/pubmed/24223763"
			"http://www.ncbi.nlm.nih.gov/pubmed/24222663"
			"http://www.ncbi.nlm.nih.gov/pubmed/24204042"
			"http://www.ncbi.nlm.nih.gov/pubmed/24197699"
			"http://www.ncbi.nlm.nih.gov/pubmed/24170344"
			"http://www.ncbi.nlm.nih.gov/pubmed/24140557"
			"http://www.ncbi.nlm.nih.gov/pubmed/24116074"
			"http://www.ncbi.nlm.nih.gov/pubmed/24102070"
			"http://www.ncbi.nlm.nih.gov/pubmed/24098377"
			"http://www.ncbi.nlm.nih.gov/pubmed/24086736"
			"http://www.ncbi.nlm.nih.gov/pubmed/24077125"
			"http://www.ncbi.nlm.nih.gov/pubmed/24076388"
			"http://www.ncbi.nlm.nih.gov/pubmed/24069188"
			"http://www.ncbi.nlm.nih.gov/pubmed/24066112"
			"http://www.ncbi.nlm.nih.gov/pubmed/24047441"
			"http://www.ncbi.nlm.nih.gov/pubmed/24038122"
			"http://www.ncbi.nlm.nih.gov/pubmed/24037538"
			"http://www.ncbi.nlm.nih.gov/pubmed/24034496"
			"http://www.ncbi.nlm.nih.gov/pubmed/24030139"
			"http://www.ncbi.nlm.nih.gov/pubmed/24013520"
			"http://www.ncbi.nlm.nih.gov/pubmed/23979427"
			"http://www.ncbi.nlm.nih.gov/pubmed/23973889"
			"http://www.ncbi.nlm.nih.gov/pubmed/23969950"
		],
		"triples": [
		],
		"id": "516425ff298dcd4e51000051",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24066112"
				"endSection": "sections.0"
				"offsetInBeginSection": "1569"
				"offsetInEndSection": "1712"
				"text": "The nuclear localization of survivin is associated with cell division, as survivin is a subunit of the chromosomal passenger complex (CPC) [8]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24069188"
				"endSection": "sections.0"
				"offsetInBeginSection": "1935"
				"offsetInEndSection": "2173"
				"text": "While a higher level of survivin at the murine feto-maternal interface was suggested to be involved in pregnancy loss, upregulated survivin was proposed to support trophoblast survival and thus maintain pregnancy during placentation [19]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24066112"
				"endSection": "sections.0"
				"offsetInBeginSection": "3322"
				"offsetInEndSection": "3417"
				"text": "These results suggested that the nuclear accumulation of survivin was linked to DNA-DSB repair."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24066112"
				"endSection": "sections.0"
				"offsetInBeginSection": "3208"
				"offsetInEndSection": "3321"
				"text": "Co-immunoprecipitation analyses revealed an interaction between survivin, Ku70 and DNA-PKcs in nuclear foci [14]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24069188"
				"endSection": "sections.0"
				"offsetInBeginSection": "1648"
				"offsetInEndSection": "1759"
				"text": "Interestingly, survivin has been reported to be overexpressed in hydatidiform mole and choriocarcinoma [16,17]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24066112"
				"endSection": "sections.0"
				"offsetInBeginSection": "2681"
				"offsetInEndSection": "2796"
				"text": "Recently it was shown that survivin is able to provoke both suppression of apoptosis and stimulation of DNA repair."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24069188"
				"endSection": "sections.0"
				"offsetInBeginSection": "232"
				"offsetInEndSection": "369"
				"text": "The gene expression of survivin is controlled by many cell signaling pathways at transcriptional and post-transcriptional levels [1,3,4]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24069188"
				"endSection": "sections.0"
				"offsetInBeginSection": "2174"
				"offsetInEndSection": "2280"
				"text": "The expression level of survivin in preeclamptic placentas has also been controversially reported [20,21]."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24066112"
				"endSection": "sections.0"
				"offsetInBeginSection": "3418"
				"offsetInEndSection": "3573"
				"text": "The aim of this study was to examine the potential correlation and prognostic value of nuclear survivin, DNA-PKcs, Ku70 and ATM using immunohistochemistry."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/24066112"
				"endSection": "sections.0"
				"offsetInBeginSection": "1294"
				"offsetInEndSection": "1428"
				"text": "The subcellular distribution of survivin plays a distinct role in the ability of this molecule to regulate cell division and survival."
			}
		],
		"id": "516425ff298dcd4e51000051",
	},
	{
		"body": "How do histone methyltransferases cause histone modification?",
		"concepts": [
		],
		"documents": [
			"http://www.ncbi.nlm.nih.gov/pubmed/24259318"
			"http://www.ncbi.nlm.nih.gov/pubmed/24169358"
			"http://www.ncbi.nlm.nih.gov/pubmed/23592277"
			"http://www.ncbi.nlm.nih.gov/pubmed/23448925"
			"http://www.ncbi.nlm.nih.gov/pubmed/23349634"
			"http://www.ncbi.nlm.nih.gov/pubmed/23002135"
			"http://www.ncbi.nlm.nih.gov/pubmed/22696466"
			"http://www.ncbi.nlm.nih.gov/pubmed/22471978"
			"http://www.ncbi.nlm.nih.gov/pubmed/22140624"
			"http://www.ncbi.nlm.nih.gov/pubmed/20821252"
			"http://www.ncbi.nlm.nih.gov/pubmed/20714703"
			"http://www.ncbi.nlm.nih.gov/pubmed/20668449"
			"http://www.ncbi.nlm.nih.gov/pubmed/20436342"
			"http://www.ncbi.nlm.nih.gov/pubmed/20230882"
			"http://www.ncbi.nlm.nih.gov/pubmed/19333872"
			"http://www.ncbi.nlm.nih.gov/pubmed/19308066"
			"http://www.ncbi.nlm.nih.gov/pubmed/18404682"
			"http://www.ncbi.nlm.nih.gov/pubmed/18000371"
			"http://www.ncbi.nlm.nih.gov/pubmed/17925448"
			"http://www.ncbi.nlm.nih.gov/pubmed/17760648"
			"http://www.ncbi.nlm.nih.gov/pubmed/17267293"
			"http://www.ncbi.nlm.nih.gov/pubmed/17168308"
			"http://www.ncbi.nlm.nih.gov/pubmed/16611076"
			"http://www.ncbi.nlm.nih.gov/pubmed/16607652"
			"http://www.ncbi.nlm.nih.gov/pubmed/16503937"
			"http://www.ncbi.nlm.nih.gov/pubmed/15024081"
			"http://www.ncbi.nlm.nih.gov/pubmed/12447821"
		],
		"triples": [
		],
		"id": "51659356298dcd4e5100005a",
	},
		"triples": [
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "11267"
				"offsetInEndSection": "11397"
				"text": "Unlike histone acetylation, histone methylation can activate or inhibit transcription, depending on where the modification occurs."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "11955"
				"offsetInEndSection": "12020"
				"text": "Similarly, histone demethylases remove methylation from histones."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "11800"
				"offsetInEndSection": "11954"
				"text": "Histone acetylation and deacetylation are dynamic processes determined by the balance between histone acetyltransferases and histone deacetylases (HDACs)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "11398"
				"offsetInEndSection": "11496"
				"text": "The methylation of histones is carried out by a large family of histone methyltransferases (HMTs)."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "10141"
				"offsetInEndSection": "10248"
				"text": "Nucleosomes package approximately 146 base pairs of DNA wrapped around an octamer of core histone proteins."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "11072"
				"offsetInEndSection": "11173"
				"text": "This process is catalyzed by histone acetyltransferases (HATs) that utilize acetyl-CoA as a cofactor."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "10904"
				"offsetInEndSection": "11071"
				"text": "Increased levels of histone acetylation are highly correlated with increased transcriptional activity, whereas decreased levels of acetylation repress gene expression."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "6131"
				"offsetInEndSection": "6265"
				"text": "DNA methylation, histone modifications, and RNA-mediated gene silencing constitute three distinct mechanisms of epigenetic regulation."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "13911"
				"offsetInEndSection": "15527"
				"text": "Despite this vast regulatory network and hundreds of microRNAs, few targets have been validated.[35]As the functions of individual microRNAs are being studied, it has become clear that microRNAs can be regulated by epigenetic mechanisms including DNA methylation and histone modification such as let-7a, miR- 9, miR-34a, miR-124, miR-137, miR-148 and miR-203.[36–40] Conversely, another subset of miRNAs controls the expression of important epigenetic regulators, including DNA methyltransferases and histone deacetylases.[41] MicroRNA-29b can reduce the expression of DNMT enzymes and thereby affect global methylation status.[42] This complex network between miRNAs and epigenetic pathways appear to form an epigenetics-miRNA regulatory circuit intertwined with the transcriptional and post-transcriptional pathways known to regulate epigenetic modulators and to organize the whole gene expression profile.[41] Though not yet demonstrated, one can conceive of situations in which potential microRNA target binding site accessibility is influenced by the methylation of the target region.Examples of epigenetic regulation of PAHSuperoxide dismutase 2Superoxide dismutase 2 (SOD2), a candidate tumor-suppressor gene,[43] is silenced in several malignancies.[4445] In multiple myeloma and pancreatic carcinoma, the epigenetic silencing of SOD2 is caused by hypermethylation of CpG islands within the promoter for SOD2.[45] SOD2 is subject both to DNA methylation and histone acetylation.[4647] Demethylation of SOD2 in cancer restores SOD2, increases H2O2 production and decreases cell proliferation and tumor growth."
			}
			{
				"beginSection": "sections.0"
				"document": "http://metal.lti.cs.cmu.edu:30002/pmc/22140624"
				"endSection": "sections.0"
				"offsetInBeginSection": "11497"
				"offsetInEndSection": "11799"
				"text": "Just like DNMTs, HMTs utilize S-adenosylmethionine (SAM) as a cofactor to methylate their target amino acids and produce S-adenosylhomocysteine (SAH) as a byproduct (Table 1).Table 1Summary of epigenetic histone modificationsAcetylation and methylation of histone tails are not permanent modifications."
			}
		],
		"id": "51659356298dcd4e5100005a",
	},
]}
